JPH0465067B2 - - Google Patents
Info
- Publication number
- JPH0465067B2 JPH0465067B2 JP62220877A JP22087787A JPH0465067B2 JP H0465067 B2 JPH0465067 B2 JP H0465067B2 JP 62220877 A JP62220877 A JP 62220877A JP 22087787 A JP22087787 A JP 22087787A JP H0465067 B2 JPH0465067 B2 JP H0465067B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- phenyl
- alkyl
- carbon atoms
- piperazino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 piperazino group Chemical group 0.000 claims abstract description 65
- FZENGILVLUJGJX-UHFFFAOYSA-N acetaldehyde oxime Chemical class CC=NO FZENGILVLUJGJX-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000002253 acid Substances 0.000 claims abstract description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 15
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 9
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 8
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims abstract description 7
- 125000001424 substituent group Chemical group 0.000 claims abstract description 6
- 125000005843 halogen group Chemical group 0.000 claims abstract description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 4
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims abstract description 4
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims abstract description 4
- 125000005110 aryl thio group Chemical group 0.000 claims abstract description 4
- 125000004104 aryloxy group Chemical group 0.000 claims abstract description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 4
- 125000003277 amino group Chemical group 0.000 claims abstract description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 claims description 2
- 239000003699 antiulcer agent Substances 0.000 abstract description 3
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000003756 stirring Methods 0.000 description 14
- 238000002844 melting Methods 0.000 description 13
- 230000008018 melting Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000000767 anti-ulcer Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 238000006146 oximation reaction Methods 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 150000003462 sulfoxides Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- UHIAKNSSBYBIJC-FMQUCBEESA-N (nz)-n-[1-[4-(benzenesulfonyl)phenyl]-2-(4-methylpiperazin-1-yl)ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1C\C(=N/O)C1=CC=C(S(=O)(=O)C=2C=CC=CC=2)C=C1 UHIAKNSSBYBIJC-FMQUCBEESA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 206010042220 Stress ulcer Diseases 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 150000008062 acetophenones Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000012433 hydrogen halide Substances 0.000 description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 description 2
- 150000002440 hydroxy compounds Chemical class 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- YYUYQAKXRVBHNZ-FMQUCBEESA-N n-[4-[(z)-n-hydroxy-c-[(4-methylpiperazin-1-yl)methyl]carbonimidoyl]phenyl]benzenesulfonamide Chemical compound C1CN(C)CCN1C\C(=N/O)C(C=C1)=CC=C1NS(=O)(=O)C1=CC=CC=C1 YYUYQAKXRVBHNZ-FMQUCBEESA-N 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- IPBVNPXQWQGGJP-UHFFFAOYSA-N phenyl acetate Chemical compound CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- MCRQFFIZXLTQEH-DQRAZIAOSA-N (ne)-n-[2-(4-methylpiperazin-1-yl)-1-[3-(2-phenylethyl)phenyl]ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1C\C(=N\O)C1=CC=CC(CCC=2C=CC=CC=2)=C1 MCRQFFIZXLTQEH-DQRAZIAOSA-N 0.000 description 1
- AFEBAKXIFPVZHU-XUTLUUPISA-N (nz)-n-[1-(4-anilinophenyl)-2-(4-methylpiperazin-1-yl)ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1C\C(=N/O)C(C=C1)=CC=C1NC1=CC=CC=C1 AFEBAKXIFPVZHU-XUTLUUPISA-N 0.000 description 1
- OUIKCUHTZSYWTP-QZQOTICOSA-N (nz)-n-[1-(4-benzylphenyl)-2-(4-methylpiperazin-1-yl)ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1C\C(=N/O)C(C=C1)=CC=C1CC1=CC=CC=C1 OUIKCUHTZSYWTP-QZQOTICOSA-N 0.000 description 1
- SJLGRMGJQFCDRZ-FMQUCBEESA-N (nz)-n-[1-(4-cyclohexylphenyl)-2-(4-methylpiperazin-1-yl)ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1C\C(=N/O)C1=CC=C(C2CCCCC2)C=C1 SJLGRMGJQFCDRZ-FMQUCBEESA-N 0.000 description 1
- XBROORITWDYOAD-FBMGVBCBSA-N (nz)-n-[1-(4-imidazol-1-ylphenyl)-2-piperidin-1-ylethylidene]hydroxylamine Chemical compound C=1C=C(N2C=NC=C2)C=CC=1C(=N/O)/CN1CCCCC1 XBROORITWDYOAD-FBMGVBCBSA-N 0.000 description 1
- FTFLRBKZJDDSLO-ZNTNEXAZSA-N (nz)-n-[1-[2-ethoxy-4-(2-phenylethyl)phenyl]-2-(4-methylpiperazin-1-yl)ethylidene]hydroxylamine Chemical compound C=1C=C(\C(CN2CCN(C)CC2)=N\O)C(OCC)=CC=1CCC1=CC=CC=C1 FTFLRBKZJDDSLO-ZNTNEXAZSA-N 0.000 description 1
- WRGVEFFGTWGGLW-HDPAMLMOSA-N (nz)-n-[1-[2-ethoxy-4-(2-phenylethyl)phenyl]-2-(4-methylpiperazin-1-yl)ethylidene]hydroxylamine;hydrochloride Chemical compound Cl.C=1C=C(\C(CN2CCN(C)CC2)=N\O)C(OCC)=CC=1CCC1=CC=CC=C1 WRGVEFFGTWGGLW-HDPAMLMOSA-N 0.000 description 1
- GSZUBSKBPHBERE-QZQOTICOSA-N (nz)-n-[2-(4-methylpiperazin-1-yl)-1-(4-phenylmethoxyphenyl)ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1C\C(=N/O)C(C=C1)=CC=C1OCC1=CC=CC=C1 GSZUBSKBPHBERE-QZQOTICOSA-N 0.000 description 1
- MOBILCWUMHLVOV-FMQUCBEESA-N (nz)-n-[2-(4-methylpiperazin-1-yl)-1-(4-phenylsulfanylphenyl)ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1C\C(=N/O)C(C=C1)=CC=C1SC1=CC=CC=C1 MOBILCWUMHLVOV-FMQUCBEESA-N 0.000 description 1
- OPAAZEDANKBRGQ-RZLHGTIFSA-N (nz)-n-[2-(4-methylpiperazin-1-yl)-1-(4-phenylsulfanylphenyl)ethylidene]hydroxylamine;hydrochloride Chemical compound Cl.C1CN(C)CCN1C\C(=N/O)C(C=C1)=CC=C1SC1=CC=CC=C1 OPAAZEDANKBRGQ-RZLHGTIFSA-N 0.000 description 1
- OERYDBODGUBLFT-QUABFQRHSA-N (nz)-n-[2-(4-methylpiperazin-1-yl)-1-[3-(2-phenylethyl)phenyl]ethylidene]hydroxylamine;hydrochloride Chemical compound Cl.C1CN(C)CCN1C\C(=N/O)C1=CC=CC(CCC=2C=CC=CC=2)=C1 OERYDBODGUBLFT-QUABFQRHSA-N 0.000 description 1
- JGJFSNFMTYCMHG-OCEACIFDSA-N (nz)-n-[2-(4-methylpiperazin-1-yl)-1-[4-(n-phenylanilino)phenyl]ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1C\C(=N/O)C1=CC=C(N(C=2C=CC=CC=2)C=2C=CC=CC=2)C=C1 JGJFSNFMTYCMHG-OCEACIFDSA-N 0.000 description 1
- GPRYKVSEZCQIHD-UHFFFAOYSA-N 1-(4-aminophenyl)ethanone Chemical compound CC(=O)C1=CC=C(N)C=C1 GPRYKVSEZCQIHD-UHFFFAOYSA-N 0.000 description 1
- LSAGEGQMBVVVQL-UHFFFAOYSA-N 1-(4-anilinophenyl)-2-chloroethanone Chemical compound C1=CC(C(=O)CCl)=CC=C1NC1=CC=CC=C1 LSAGEGQMBVVVQL-UHFFFAOYSA-N 0.000 description 1
- MKYMYZJJFMPDOA-UHFFFAOYSA-N 1-(4-phenylmethoxyphenyl)ethanone Chemical compound C1=CC(C(=O)C)=CC=C1OCC1=CC=CC=C1 MKYMYZJJFMPDOA-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- JCYYURYXDAOACZ-UHFFFAOYSA-N 1-[3-(2-phenylethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(CCC=2C=CC=CC=2)=C1 JCYYURYXDAOACZ-UHFFFAOYSA-N 0.000 description 1
- LAWOOMZUOLLFHK-UHFFFAOYSA-N 1-bromo-3-(2-phenylethyl)benzene Chemical compound BrC1=CC=CC(CCC=2C=CC=CC=2)=C1 LAWOOMZUOLLFHK-UHFFFAOYSA-N 0.000 description 1
- DSCJETUEDFKYGN-UHFFFAOYSA-N 2-Methoxybenzenethiol Chemical compound COC1=CC=CC=C1S DSCJETUEDFKYGN-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- 238000005618 Fries rearrangement reaction Methods 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- FRLTZFRFAWAIJF-UHFFFAOYSA-N n-[1-(4-phenylsulfanylphenyl)ethylidene]hydroxylamine Chemical compound C1=CC(C(=NO)C)=CC=C1SC1=CC=CC=C1 FRLTZFRFAWAIJF-UHFFFAOYSA-N 0.000 description 1
- GJBOAULYVPDFIU-UHFFFAOYSA-N n-[2-(4-methylpiperazin-1-yl)-1-(4-phenylmethoxyphenyl)ethylidene]hydroxylamine;hydrochloride Chemical compound Cl.C1CN(C)CCN1CC(=NO)C(C=C1)=CC=C1OCC1=CC=CC=C1 GJBOAULYVPDFIU-UHFFFAOYSA-N 0.000 description 1
- MOBILCWUMHLVOV-UHFFFAOYSA-N n-[2-(4-methylpiperazin-1-yl)-1-(4-phenylsulfanylphenyl)ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1CC(=NO)C(C=C1)=CC=C1SC1=CC=CC=C1 MOBILCWUMHLVOV-UHFFFAOYSA-N 0.000 description 1
- MCRQFFIZXLTQEH-UHFFFAOYSA-N n-[2-(4-methylpiperazin-1-yl)-1-[3-(2-phenylethyl)phenyl]ethylidene]hydroxylamine Chemical compound C1CN(C)CCN1CC(=NO)C1=CC=CC(CCC=2C=CC=CC=2)=C1 MCRQFFIZXLTQEH-UHFFFAOYSA-N 0.000 description 1
- OBAUYACNAJICFC-UHFFFAOYSA-N n-[4-(2-chloroacetyl)phenyl]-n-phenylacetamide Chemical compound C=1C=C(C(=O)CCl)C=CC=1N(C(=O)C)C1=CC=CC=C1 OBAUYACNAJICFC-UHFFFAOYSA-N 0.000 description 1
- UOZQZHNAFDYKPM-QZQOTICOSA-N n-[4-[(z)-n-hydroxy-c-[(4-methylpiperazin-1-yl)methyl]carbonimidoyl]phenyl]-4-methylbenzenesulfonamide Chemical compound C1CN(C)CCN1C\C(=N/O)C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 UOZQZHNAFDYKPM-QZQOTICOSA-N 0.000 description 1
- VLOMTIDCGJMJPN-QURGRASLSA-N n-[4-[(z)-n-hydroxy-c-[(4-methylpiperazin-1-yl)methyl]carbonimidoyl]phenyl]-n-phenylacetamide Chemical compound C1CN(C)CCN1C\C(=N/O)C1=CC=C(N(C(C)=O)C=2C=CC=CC=2)C=C1 VLOMTIDCGJMJPN-QURGRASLSA-N 0.000 description 1
- HIJWKFFKGDXMCP-UHFFFAOYSA-N n-[4-[2-(4-methylpiperazin-1-yl)acetyl]phenyl]acetamide Chemical compound C1CN(C)CCN1CC(=O)C1=CC=C(NC(C)=O)C=C1 HIJWKFFKGDXMCP-UHFFFAOYSA-N 0.000 description 1
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical class ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000005671 trienes Chemical class 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C07D279/30—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with acyl radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
ãç£æ¥äžã®å©çšåéã
æ¬çºæã¯æ°èŠãªããšã¿ãã³ãªãã·ã é¡ã«é¢ã
ããæ¬çºæã®ãšã¿ãã³ãªãã·ã é¡ããã³è¬å€ãšã
ãŠèš±å®¹ããããã®é žä»å å¡©ã¯ãããããæ朰çäœ
çšãæããã ãåŸæ¥ã®æè¡åã³çºæã解決ããããšããåé¡
ç¹ã åŸæ¥ãæ朰çäœçšãæããç©è³ªãšããŠçš®ã ã®å
åç©ãææ¡ãããŠããããªãããããè¿æããã¹
ã¿ãã³H2âãããã«ãŒã§ããã·ã¡ããžã³ã¯ãã
ã®åªããæ朰çäœçšã«ããåºãçšããããŠãã
ããäžæ¹ãåçºãªã©ããã€ãã®åé¡ç¹ãæããæ
ããææããã€ã€ããïŒããšãã°ãNIKKEI
MEDICAL1984幎ïŒæ14æ¥å·26â34é ãïŒã æ¬çºæè ãã¯ãåŸæ¥ææ¡ãããŠããååç©ãšæ§
é ãç°ã«ããåªããæ朰çäœçšãæããååç©ã
èŠåºãã¹ãããªãã·ã ç³»ååç©ã«çç®ããŠçš®ã æ€
èšããã æ朰ç掻æ§ã瀺ããªãã·ã ç³»ååç©ãšããŠãç¹
éæ55â19287å·å ¬å ±ã«ãªãã·ã ãšãŒãã«èªå°äœ
ãèšèŒãããŠããããæ¬çºæè ãã¯æŽã«é«ãæ朰
ç掻æ§ã瀺ãååç©ãåŸãã¹ãçš®ã æ€èšããçµ
æãæ°èŠãªãšã¿ãã³ãªãã·ã é¡ã«ãã€ãŠææã®ç®
çãéæãããããšãèŠãåºããæ¬çºæãå®æã
ãã«è³ã€ãã ãåé¡ç¹ã解決ããããã®æ段ã ããªãã¡ãæ¬çºæã®èŠæšã¯ãäžèšäžè¬åŒïŒïŒ ãäžèšåŒäžãR1ã¯ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åºã
ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºåã³ããã²ã³ååã
ãéžã°ãã眮æåºã§çœ®æãããŠããŠãããã·ã¯ã
ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ã©ã«ãã«åºãã¢ãªãŒ
ã«ãªãã·åºãã¢ã©ã«ãã«ãªãã·åºãã¢ãªãŒã«ããª
åºãè¥ããã¯ã¢ãªãŒã«ã¹ã«ããã«åºããããªãžã
åºãããã©ãžãåºãïŒâã¢ã«ãã«çœ®æããã©ãžã
åºãã€ãããŸãªã«åºãïŒâã¢ã«ãã«çœ®æã€ãããŸ
ãªã«åºãŸãã¯ããšãã«åºãã¢ã»ãã«åºããã³ãŒã³
ã¹ã«ããã«åºããã³ïœâãã«ãšã³ã¹ã«ããã«åºã
ãéžã°ããïŒä»¥äžã®çœ®æåºã§çœ®æãããã¢ããåº
ãè¡šããã R2ã¯æ°ŽçŽ ååãŸãã¯ççŽ æ°ïŒãïŒã®ã¢ã«ã³ã
ã·åºãè¡šããã R3ã¯ãããªãžãåºãããã©ãžãåºãŸãã¯ïŒâ
ã¢ã«ãã«çœ®æããã©ãžãåºãè¡šããã ãŸããR1åã³R2ã¯äºãã«çµåããŠããšãã«åº
ãšå ±ã«ããšããã¢ãžã³âïŒâã€ã«åºãâã¢ã»ã
ã«âããšããã¢ãžã³âïŒâã€ã«åºããã¢ã³ãã¬ã³
âïŒâã€ã«åºããžãã³ãŸããªããšã³âïŒâã€ã«
åºããžãã³ãŸãã©ã³âïŒâã€ã«åºè¥ããã¯æ¬¡åŒ
ããæ¬çºæã®ãšã¿ãã³ãªãã·ã é¡ããã³è¬å€ãšã
ãŠèš±å®¹ããããã®é žä»å å¡©ã¯ãããããæ朰çäœ
çšãæããã ãåŸæ¥ã®æè¡åã³çºæã解決ããããšããåé¡
ç¹ã åŸæ¥ãæ朰çäœçšãæããç©è³ªãšããŠçš®ã ã®å
åç©ãææ¡ãããŠããããªãããããè¿æããã¹
ã¿ãã³H2âãããã«ãŒã§ããã·ã¡ããžã³ã¯ãã
ã®åªããæ朰çäœçšã«ããåºãçšããããŠãã
ããäžæ¹ãåçºãªã©ããã€ãã®åé¡ç¹ãæããæ
ããææããã€ã€ããïŒããšãã°ãNIKKEI
MEDICAL1984幎ïŒæ14æ¥å·26â34é ãïŒã æ¬çºæè ãã¯ãåŸæ¥ææ¡ãããŠããååç©ãšæ§
é ãç°ã«ããåªããæ朰çäœçšãæããååç©ã
èŠåºãã¹ãããªãã·ã ç³»ååç©ã«çç®ããŠçš®ã æ€
èšããã æ朰ç掻æ§ã瀺ããªãã·ã ç³»ååç©ãšããŠãç¹
éæ55â19287å·å ¬å ±ã«ãªãã·ã ãšãŒãã«èªå°äœ
ãèšèŒãããŠããããæ¬çºæè ãã¯æŽã«é«ãæ朰
ç掻æ§ã瀺ãååç©ãåŸãã¹ãçš®ã æ€èšããçµ
æãæ°èŠãªãšã¿ãã³ãªãã·ã é¡ã«ãã€ãŠææã®ç®
çãéæãããããšãèŠãåºããæ¬çºæãå®æã
ãã«è³ã€ãã ãåé¡ç¹ã解決ããããã®æ段ã ããªãã¡ãæ¬çºæã®èŠæšã¯ãäžèšäžè¬åŒïŒïŒ ãäžèšåŒäžãR1ã¯ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åºã
ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºåã³ããã²ã³ååã
ãéžã°ãã眮æåºã§çœ®æãããŠããŠãããã·ã¯ã
ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ã©ã«ãã«åºãã¢ãªãŒ
ã«ãªãã·åºãã¢ã©ã«ãã«ãªãã·åºãã¢ãªãŒã«ããª
åºãè¥ããã¯ã¢ãªãŒã«ã¹ã«ããã«åºããããªãžã
åºãããã©ãžãåºãïŒâã¢ã«ãã«çœ®æããã©ãžã
åºãã€ãããŸãªã«åºãïŒâã¢ã«ãã«çœ®æã€ãããŸ
ãªã«åºãŸãã¯ããšãã«åºãã¢ã»ãã«åºããã³ãŒã³
ã¹ã«ããã«åºããã³ïœâãã«ãšã³ã¹ã«ããã«åºã
ãéžã°ããïŒä»¥äžã®çœ®æåºã§çœ®æãããã¢ããåº
ãè¡šããã R2ã¯æ°ŽçŽ ååãŸãã¯ççŽ æ°ïŒãïŒã®ã¢ã«ã³ã
ã·åºãè¡šããã R3ã¯ãããªãžãåºãããã©ãžãåºãŸãã¯ïŒâ
ã¢ã«ãã«çœ®æããã©ãžãåºãè¡šããã ãŸããR1åã³R2ã¯äºãã«çµåããŠããšãã«åº
ãšå ±ã«ããšããã¢ãžã³âïŒâã€ã«åºãâã¢ã»ã
ã«âããšããã¢ãžã³âïŒâã€ã«åºããã¢ã³ãã¬ã³
âïŒâã€ã«åºããžãã³ãŸããªããšã³âïŒâã€ã«
åºããžãã³ãŸãã©ã³âïŒâã€ã«åºè¥ããã¯æ¬¡åŒ
ãåŒã
ïŒåŒäžãR4ã¯æ°ŽçŽ ååãŸãã¯ççŽ æ°ïŒãïŒã®
ã¢ã«ãã«åºãè¡šãããïŒã§ç€ºãããåºãè¡šãããŠ
ããããã ã§è¡šãããããšã¿ãã³ãªãã·ã é¡ãŸãã¯è¬å€ãšã
ãŠèš±å®¹ããããã®é žä»å å¡©ã«åããã 以äžæ¬çºæã詳现ã«èª¬æããã«ãæ¬çºæã®ãšã¿
ãã³ãªãã·ã é¡ã¯ãåèšäžè¬åŒïŒïŒã§è¡šããã
ããã®ã§ããã åŒäžãR1ã¯ã·ã¯ãããã·ã«åºãã·ã¯ããã³ã
ã«åºçã®ã·ã¯ãã¢ã«ãã«åºãããšãã«åºçã®ã¢ãª
ãŒã«åºããã³ãžã«åºãããšããã«åºçã®ã¢ã©ã«ã
ã«åºãããšããã·åºçã®ã¢ãªãŒã«ãªãã·åºããã³
ãžã«ãªãã·åºãããšããã«ãªãã·åºçã®ã¢ã©ã«ã
ã«ãªãã·åºãããšãã«ããªåºçã®ã¢ãªãŒã«ããªåº
è¥ããã¯ããšãã«ã¹ã«ããã«åºçã®ã¢ãªãŒã«ã¹ã«
ããã«åºãè¡šããããããã¯ã¡ãã«åºããšãã«
åºããããã«åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åºã
ã¡ããã·åºããšããã·åºãããããã·åºçã®ççŽ
æ°ïŒãïŒã®ã¢ã«ã³ãã·åºæãã¯å¡©çŽ ååãèçŽ å
åçã®ããã²ã³ååã§çœ®æãããŠããŠãããã ãŸããR1ã¯ïŒâãããªãžãåºçã®ãããªãžã
åºãïŒâããã©ãžãåºçã®ããã©ãžãåºãïŒâã¡
ãã«âïŒâããã©ãžãåºãïŒâãšãã«âïŒâãã
ã©ãžãåºãïŒâãããã«âïŒâããã©ãžãåºçã®
ïŒâã¢ã«ãã«çœ®æããã©ãžãåºãã€ãããŸãŒã«â
ïŒâã€ã«åºçã®ã€ãããŸãªã«åºè¥ããã¯ïŒâã¡ã
ã«ã€ãããŸãŒã«âïŒâã€ã«åºãïŒâãšãã«ã€ãã
ãŸãŒã«âïŒâã€ã«åºçã®ïŒâã¢ã«ãã«çœ®æã€ãã
ãŸãªã«åºãè¡šããã ãŸããR1ã¯ããšãã«ã¢ããåºããžããšãã«ã¢
ããåºãâã¢ã»ãã«âã¢ããªãåºããã³ãŒã³ã¹
ã«ããã«ã¢ããåºããã©ãã«ãšã³ã¹ã«ããã«ã¢ã
ãåºçã®çœ®æã¢ããåºãè¡šããã R2ã¯æ°ŽçŽ ååãŸãã¯ã¡ããã·åºããšããã·åºã
ããããã·åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºã
è¡šãããR3ã¯ãããªãžãåºãããã©ãžãåºãŸã
ã¯ïŒâã¢ã«ãã«çœ®æããã©ãžãåºãäŸãã°ãïŒâ
ã¡ãã«âïŒâããã©ãžãåºãïŒâãšãã«âïŒâã
ãã©ãžãåºãïŒâãããã«âïŒâããã©ãžãåºç
ãè¡šããã æŽã«ãŸããR1ãšR2ã¯äºãã«çµåããŠããšãã«
åºãšå ±ã«ããšããã¢ãžã³âïŒâã€ã«åºãâã¢ã»
ãã«âããšããã¢ãžã³âïŒâã€ã«åºããã¢ã³ãã¬
ã³âïŒâã€ã«åºããžãã³ãŸããªããšã³âïŒâã€ã«
åºããžãã³ãŸãã©ã³âïŒâã€ã«åºè¥ããã¯åŒ
ã¢ã«ãã«åºãè¡šãããïŒã§ç€ºãããåºãè¡šãããŠ
ããããã ã§è¡šãããããšã¿ãã³ãªãã·ã é¡ãŸãã¯è¬å€ãšã
ãŠèš±å®¹ããããã®é žä»å å¡©ã«åããã 以äžæ¬çºæã詳现ã«èª¬æããã«ãæ¬çºæã®ãšã¿
ãã³ãªãã·ã é¡ã¯ãåèšäžè¬åŒïŒïŒã§è¡šããã
ããã®ã§ããã åŒäžãR1ã¯ã·ã¯ãããã·ã«åºãã·ã¯ããã³ã
ã«åºçã®ã·ã¯ãã¢ã«ãã«åºãããšãã«åºçã®ã¢ãª
ãŒã«åºããã³ãžã«åºãããšããã«åºçã®ã¢ã©ã«ã
ã«åºãããšããã·åºçã®ã¢ãªãŒã«ãªãã·åºããã³
ãžã«ãªãã·åºãããšããã«ãªãã·åºçã®ã¢ã©ã«ã
ã«ãªãã·åºãããšãã«ããªåºçã®ã¢ãªãŒã«ããªåº
è¥ããã¯ããšãã«ã¹ã«ããã«åºçã®ã¢ãªãŒã«ã¹ã«
ããã«åºãè¡šããããããã¯ã¡ãã«åºããšãã«
åºããããã«åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åºã
ã¡ããã·åºããšããã·åºãããããã·åºçã®ççŽ
æ°ïŒãïŒã®ã¢ã«ã³ãã·åºæãã¯å¡©çŽ ååãèçŽ å
åçã®ããã²ã³ååã§çœ®æãããŠããŠãããã ãŸããR1ã¯ïŒâãããªãžãåºçã®ãããªãžã
åºãïŒâããã©ãžãåºçã®ããã©ãžãåºãïŒâã¡
ãã«âïŒâããã©ãžãåºãïŒâãšãã«âïŒâãã
ã©ãžãåºãïŒâãããã«âïŒâããã©ãžãåºçã®
ïŒâã¢ã«ãã«çœ®æããã©ãžãåºãã€ãããŸãŒã«â
ïŒâã€ã«åºçã®ã€ãããŸãªã«åºè¥ããã¯ïŒâã¡ã
ã«ã€ãããŸãŒã«âïŒâã€ã«åºãïŒâãšãã«ã€ãã
ãŸãŒã«âïŒâã€ã«åºçã®ïŒâã¢ã«ãã«çœ®æã€ãã
ãŸãªã«åºãè¡šããã ãŸããR1ã¯ããšãã«ã¢ããåºããžããšãã«ã¢
ããåºãâã¢ã»ãã«âã¢ããªãåºããã³ãŒã³ã¹
ã«ããã«ã¢ããåºããã©ãã«ãšã³ã¹ã«ããã«ã¢ã
ãåºçã®çœ®æã¢ããåºãè¡šããã R2ã¯æ°ŽçŽ ååãŸãã¯ã¡ããã·åºããšããã·åºã
ããããã·åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºã
è¡šãããR3ã¯ãããªãžãåºãããã©ãžãåºãŸã
ã¯ïŒâã¢ã«ãã«çœ®æããã©ãžãåºãäŸãã°ãïŒâ
ã¡ãã«âïŒâããã©ãžãåºãïŒâãšãã«âïŒâã
ãã©ãžãåºãïŒâãããã«âïŒâããã©ãžãåºç
ãè¡šããã æŽã«ãŸããR1ãšR2ã¯äºãã«çµåããŠããšãã«
åºãšå ±ã«ããšããã¢ãžã³âïŒâã€ã«åºãâã¢ã»
ãã«âããšããã¢ãžã³âïŒâã€ã«åºããã¢ã³ãã¬
ã³âïŒâã€ã«åºããžãã³ãŸããªããšã³âïŒâã€ã«
åºããžãã³ãŸãã©ã³âïŒâã€ã«åºè¥ããã¯åŒ
ãåŒã
ïŒåŒäžãR4ã¯æ°ŽçŽ ååãŸãã¯ã¡ãã«åºããšã
ã«åºããããã«åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åº
ãè¡šãããïŒã§ç€ºãããåºãè¡šãããŠãããã æ¬çºæã®å¥œãŸããååç©ãšããŠã¯ãåŒäžãR1
ãåè¿°ã®çœ®æåºãæããŠããŠãããã·ã¯ãããã·
ã«åºããã³ãžã«åºãããšããã«åºããã³ãžã«ãªã
ã·åºãããšãã«ããªåºè¥ããã¯ããšãã«ã¹ã«ãã
ã«åºããŸãã¯ãã€ãããŸãŒã«âïŒâã€ã«åºããžã
ãšãã«ã¢ããåºãâã¢ã»ãã«âã¢ããªãåºãã
ã³ãŒã³ã¹ã«ããã«ã¢ããåºãè¡šããããR1ãšR2
ãäºãã«çµåããŠããšãã«åºãšå ±ã«ããšããã¢ãž
ã³âïŒâã€ã«åºãâã¢ã»ãã«âããšããã¢ãžã³
âïŒâã€ã«åºè¥ããã¯åŒ
ã«åºããããã«åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åº
ãè¡šãããïŒã§ç€ºãããåºãè¡šãããŠãããã æ¬çºæã®å¥œãŸããååç©ãšããŠã¯ãåŒäžãR1
ãåè¿°ã®çœ®æåºãæããŠããŠãããã·ã¯ãããã·
ã«åºããã³ãžã«åºãããšããã«åºããã³ãžã«ãªã
ã·åºãããšãã«ããªåºè¥ããã¯ããšãã«ã¹ã«ãã
ã«åºããŸãã¯ãã€ãããŸãŒã«âïŒâã€ã«åºããžã
ãšãã«ã¢ããåºãâã¢ã»ãã«âã¢ããªãåºãã
ã³ãŒã³ã¹ã«ããã«ã¢ããåºãè¡šããããR1ãšR2
ãäºãã«çµåããŠããšãã«åºãšå ±ã«ããšããã¢ãž
ã³âïŒâã€ã«åºãâã¢ã»ãã«âããšããã¢ãžã³
âïŒâã€ã«åºè¥ããã¯åŒ
ãåŒã
ïŒåŒäžãR4ã¯åèšãšåãïŒã§ç€ºãããåºãè¡š
ãããR3ãïŒâãããªãžãåºãŸãã¯ïŒâã¢ã«ã
ã«âïŒâããã©ãžãåºãè¡šããååç©ãæããã
ãã ç¹ã«ãR1ããã©äœã«çœ®æããååç©ã奜é©ã§
ããã ããã«ãæ¬çºæã®å¥œãŸããå ·äœçãªååç©ãäŸ
瀺ããã°ä»¥äžã®ãšããã§ããã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâããšãã«ããªâããšãã«ïŒâãš
ã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâã·ã¯ãããã·ã«âããšãã«ïŒâ
ãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãã³ãžã«âããšãã«ïŒâãšã¿ã
ã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïŒ®âã¢ã»ãã«ââããšãã«
âã¢ããïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãžããšãã«ã¢ããâããšãã«ïŒ
âãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïŒâããšãã«ããã«ïŒâããšã
ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒãããªãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâïŒïŒâããšãã«ãšãã«ïŒâããšãã«ïŒâãšã¿
ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒ®âã¢ã»ãã«âããšããã¢ãžã³âïŒ
âã€ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒãããªãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒ®âã¢ã»ãã«âããšããã¢ãžã³âïŒâã€ã«ïŒâ
ãšã¿ãã³ãªãã·ã â ïŒïŒ¥ïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒ10ïŒ11âãžãããâ5Hâãžãã³ãŸ
ãïœïŒïœãã·ã¯ããããã³âïŒâã€ã«ïŒâãšã¿ã
ã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒ10ïŒ11âãžãããâ5HâïŒâã¡ã
ã«âãžãã³ãŸãïœïŒïœãã·ã¯ããããã³âïŒâ
ã€ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒ10ïŒ11âãžãããâ5HâïŒâãšã
ã«âãžãã³ãŸãïœïŒïœãã·ã¯ããããã³âïŒâ
ã€ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâããšãã«ã¹ã«ããã«âããšã
ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒããšããã¢ãžã³âïŒâã€ã«ïŒâãšã¿
ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒã€ãããŸãŒã«âïŒâã€ã«ïŒâã
ãšãã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒãããªãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâïŒã€ãããŸãŒã«âïŒâã€ã«ïŒâããšãã«ïŒâ
ãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãã³ãŒã³ã¹ã«ããã«ã¢ããâã
ãšãã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãã³ãžã«ãªãã·âããšãã«ïŒâ
ãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãšããã·âïŒâïŒïŒâããšãã«
ãšãã«ïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïŒâïŒïŒâã€ãœããããã·âã
ãšãã«ïŒâãšãã«ïŒâããšãã«ïŒâãšã¿ãã³ãªã
ã·ã äžèšãããšã¿ãã³ãªãã·ã é¡ã®é žä»å å¡©ãæ¬çº
æã®ç¯å²ã«å«ãŸããã ãã®ãããªé žä»å å¡©ãšããŠã¯ãå¡©åæ°ŽçŽ é žå¡©ã
èåæ°ŽçŽ é žå¡©ãç¡«é žå¡©ããªã³é žå¡©ãç¡é žå¡©ãé ¢é ž
å¡©ãã³ãã¯é žå¡©ãã¢ãžãã³é žå¡©ãããããªã³é ž
å¡©ãé ç³é žå¡©ããã¬ã€ã³é žå¡©ãã¯ãšã³é žå¡©ãå®æ¯
éŠé žå¡©ããã«ãšã³ã¹ã¹ã«ãã³é žå¡©ãã¡ã¿ã³ã¹ã«ã
ã³é žå¡©çã®é žä»å å¡©ãæããããã 以äžã«æ¬çºæååç©ã®è£œé æ³ã説æããã äžèšäžè¬åŒïŒïŒã§è¡šããããæ¬çºæã®ãšã¿ã
ã³ãªãã·ã é¡ã¯ã äžè¬åŒïŒïŒïŒR1ãR3ã¯äžèšäžè¬åŒïŒïŒäžã§
å®çŸ©ãããšããã§ãããïŒã§ç€ºãããã¢ããã±ã
ã³ããå ¬ç¥ã®æ¹æ³ã§ãªãã·ã åïŒããããã·ã€ã
ãåïŒããããšã«ããåŸãããããªãã·ã åã«äœ¿
çšãããããããã·ã«ã¢ãã³ã¯éé¢ã®åœ¢ã§ãå¡©é ž
å¡©ã®åœ¢ã§ã䜿çšããããããããã·ã«ã¢ãã³ã®äœ¿
çšéã¯ïŒïŒã«å¯ŸããŠïŒã20åœéã§ããã åå¿ã¯ãã¡ã¿ããŒã«ããšã¿ããŒã«çã®ã¢ã«ã³ãŒ
ã«ç³»æº¶åªïŒãžã¡ãã«ãã«ã ã¢ãããâã¡ãã«â
ïŒâãããªãžãã³çã®ã¢ãã系溶åªïŒãžã¡ãã«ã¹
ã«ããã·ãçã®ã¹ã«ããã·ã系溶åªïŒããã©ãã
ããã©ã³ããžãªããµã³çã®ãšãŒãã«ç³»æº¶åªïŒããª
ãžã³ãããªãšãã«ã¢ãã³çã®å¡©åºæ§æº¶åªãæ°Žäžã§
è¡ãªããããããããã¯ãããã®ïŒçš®ä»¥äžã®æº¶åª
ã®æ··åç©ãçšããããã ããããã·ã«ã¢ãã³ãå¡©é žå¡©ã®åœ¢ã§äœ¿çšããå Ž
åã«ã¯ãéåžžãããšåœé以äžã®ããªãžã³ãããªãš
ãã«ã¢ãã³çã®ç¬¬ïŒçŽã¢ãã³é¡ãããããã¯æ°Žé ž
åãããªãŠã ãæ°Žé žåã«ãªãŠã ãçé žã«ãªãŠã ã
çé žãããªãŠã çã®ç¡æ©å¡©é¡ãšäžèšæº¶åªäžã«æ·»å
ããŠåå¿ãè¡ãªãããã åå¿æž©åºŠã¯ãâ20âã
150âã奜ãŸããã¯ïŒâã100âã§ããã äžè¿°ã®ãªãã·ã ååå¿ã«ãããç°æ§äœããã³
ç°æ§äœã®ïŒçš®ãçæããããæ¬çºæã«ãããŠ
ã¯ãïŒçš®ã®ç°æ§äœã®æ··åç©ã®åœ¢ã§ãããããã¯å
ç°æ§äœã«åé¢ããåŸãåäžã®ç°æ§äœã®åœ¢ã§ãã
ãã éåžžã¯åå¿åŸãäžè¬åŒïŒïŒã§è¡šãããããšã¿
ãã³ãªãã·ã é¡ãéé¢å¡©åºã®åœ¢ã§åãåºããåŸã
åçµæ¶æ³ãã«ã©ã ã¯ãããæ³çæ £çšã®æ段ãçšã
ãŠãããããåäžã®ç°æ§äœãåŸãããšãã§ããã
ææã«ãããäžè¬åŒïŒïŒã®ãšã¿ãã³ãªãã·ã é¡
ããæãŸããé žãšæ¥è§Šãããããšã«ãããé žä»å
å¡©ã®åœ¢ã§åŸãããšãã§ããã äžèšåå¿ã®åæã§ããäžè¬åŒïŒïŒã§ç€ºããã
ã¢ããã±ãã³é¡ã¯äžèšã®åæ¹æ³ã§è£œé ããããšã
ã§ããã ïŒäžèšåŒäžã®R1ãR2ãR3ã¯ãäžèšäžè¬åŒïŒïŒ
äžã§å®çŸ©ãããšããã§ãããã¯å¡©çŽ ååçã®ã
ãã²ã³ååãè¡šãããïŒ äžè¬åŒïŒïŒã§è¡šããããαâããã¢ã»ãããš
ãã³é¡ãšäžè¬åŒïŒïŒã§è¡šããããã¢ãã³é¡ãå
å¿ãããããšã«ãããäžè¬åŒïŒïŒã§è¡šãããã
ã¢ããã±ãã³é¡ãåŸãããšãã§ããããã®ã¢ãã
ååå¿ã«ãããã¢ãã³é¡ã®äœ¿çšéã¯ïŒïŒã«å¯Ÿã
éåžžåœã¢ã«ä»¥äžã§ããã åå¿ã¯ç¡æº¶åªã§ãé²è¡ãããããžãªããµã³ãã
ãã©ããããã©ã³çã®ãšãŒãã«ç³»æº¶åªïŒãžã¡ãã«
ãã«ã ã¢ãããâã¡ãã«âïŒâãããªãžãã³ç
ã®ã¢ãã系溶åªïŒã¡ã¿ããŒã«ããšã¿ããŒã«çã®ã¢
ã«ã³ãŒã«ç³»æº¶åªïŒæ°Žãããã¯ãããïŒçš®ä»¥äžã®æ··
åç©çåå¿ã«äžæŽ»æ§ãªæº¶åªã䜿çšã§ãããåå¿æž©
床ã¯ç¹ã«éå®ãããªããéåžž0°ã150âã§ããã
ãŸãåå¿ã«ããçããããã²ã³åæ°ŽçŽ ãæéããŠ
åå¿ãä¿é²ãããããã«ãå¡©åºé¡ãæ·»å ããŠãã
ããå¡©åºé¡ãšããŠã¯ãæ°Žé žåãããªãŠã ãæ°Žé žå
ã«ãªãŠã ãçé žãããªãŠã ãçé žã«ãªãŠã çã®ç¡
æ©å¡©åºé¡ïŒããªãžã³ãããªãšãã«ã¢ãã³çã®ç¬¬ïŒ
çŽã¢ãã³é¡ã䜿çšããããå¡©åºé¡ã®äœ¿çšéã¯éåžž
ïŒïŒã«å¯Ÿãåœã¢ã«ä»¥äžã§ãããç®çç©ã§ããã¢
ããã±ãã³é¡ïŒïŒã¯ãåå¿æ¡ä»¶ã«ããéé¢å¡©åº
ã®åœ¢ãããã¯ããã²ã³åæ°ŽçŽ ãšã®é žä»å å¡©ã®åœ¢ã®
ãããããææãã圢ã§åŸãããã æ¬åå¿ã¯ãé«åçã§é²è¡ãããããåŸãããã¢
ããã±ãã³é¡ïŒïŒã¯ç²Ÿè£œãè¡ãªããã«å ã«è¿°ã¹
ããªãã·ã ååå¿ã«äœ¿çšã§ããããããã¯ãçæ
ããã¢ããã±ãã³é¡ïŒïŒã®åå¿æ··åç©ã«ããã
ãã·ã«ã¢ãã³ãæ·»å ããããšã«ãããé£ç¶ããŠãª
ãã·ã ååå¿ãå®æœããããšãã§ããã ïŒäžèšåŒäžã®R3ã¯äžè¬åŒïŒïŒã§å®çŸ©ãããš
ããã§ãããR6ã¯ã€ãããŸãŒã«âïŒâã€ã«åºã
ïŒâã¡ãã«ã€ãããŸãŒã«âïŒâã€ã«åºãïŒâãã
ãªãžãåºãïŒâã¡ãã«âïŒâããã©ãžãåºã
ãããR3ãïŒâãããªãžãåºãŸãã¯ïŒâã¢ã«ã
ã«âïŒâããã©ãžãåºãè¡šããååç©ãæããã
ãã ç¹ã«ãR1ããã©äœã«çœ®æããååç©ã奜é©ã§
ããã ããã«ãæ¬çºæã®å¥œãŸããå ·äœçãªååç©ãäŸ
瀺ããã°ä»¥äžã®ãšããã§ããã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâããšãã«ããªâããšãã«ïŒâãš
ã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâã·ã¯ãããã·ã«âããšãã«ïŒâ
ãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãã³ãžã«âããšãã«ïŒâãšã¿ã
ã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïŒ®âã¢ã»ãã«ââããšãã«
âã¢ããïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãžããšãã«ã¢ããâããšãã«ïŒ
âãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïŒâããšãã«ããã«ïŒâããšã
ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒãããªãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâïŒïŒâããšãã«ãšãã«ïŒâããšãã«ïŒâãšã¿
ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒ®âã¢ã»ãã«âããšããã¢ãžã³âïŒ
âã€ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒãããªãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒ®âã¢ã»ãã«âããšããã¢ãžã³âïŒâã€ã«ïŒâ
ãšã¿ãã³ãªãã·ã â ïŒïŒ¥ïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒ10ïŒ11âãžãããâ5Hâãžãã³ãŸ
ãïœïŒïœãã·ã¯ããããã³âïŒâã€ã«ïŒâãšã¿ã
ã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒ10ïŒ11âãžãããâ5HâïŒâã¡ã
ã«âãžãã³ãŸãïœïŒïœãã·ã¯ããããã³âïŒâ
ã€ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒ10ïŒ11âãžãããâ5HâïŒâãšã
ã«âãžãã³ãŸãïœïŒïœãã·ã¯ããããã³âïŒâ
ã€ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâããšãã«ã¹ã«ããã«âããšã
ã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒããšããã¢ãžã³âïŒâã€ã«ïŒâãšã¿
ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒã€ãããŸãŒã«âïŒâã€ã«ïŒâã
ãšãã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒãããªãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâïŒã€ãããŸãŒã«âïŒâã€ã«ïŒâããšãã«ïŒâ
ãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãã³ãŒã³ã¹ã«ããã«ã¢ããâã
ãšãã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãã³ãžã«ãªãã·âããšãã«ïŒâ
ãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãšããã·âïŒâïŒïŒâããšãã«
ãšãã«ïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã â ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïŒâïŒïŒâã€ãœããããã·âã
ãšãã«ïŒâãšãã«ïŒâããšãã«ïŒâãšã¿ãã³ãªã
ã·ã äžèšãããšã¿ãã³ãªãã·ã é¡ã®é žä»å å¡©ãæ¬çº
æã®ç¯å²ã«å«ãŸããã ãã®ãããªé žä»å å¡©ãšããŠã¯ãå¡©åæ°ŽçŽ é žå¡©ã
èåæ°ŽçŽ é žå¡©ãç¡«é žå¡©ããªã³é žå¡©ãç¡é žå¡©ãé ¢é ž
å¡©ãã³ãã¯é žå¡©ãã¢ãžãã³é žå¡©ãããããªã³é ž
å¡©ãé ç³é žå¡©ããã¬ã€ã³é žå¡©ãã¯ãšã³é žå¡©ãå®æ¯
éŠé žå¡©ããã«ãšã³ã¹ã¹ã«ãã³é žå¡©ãã¡ã¿ã³ã¹ã«ã
ã³é žå¡©çã®é žä»å å¡©ãæããããã 以äžã«æ¬çºæååç©ã®è£œé æ³ã説æããã äžèšäžè¬åŒïŒïŒã§è¡šããããæ¬çºæã®ãšã¿ã
ã³ãªãã·ã é¡ã¯ã äžè¬åŒïŒïŒïŒR1ãR3ã¯äžèšäžè¬åŒïŒïŒäžã§
å®çŸ©ãããšããã§ãããïŒã§ç€ºãããã¢ããã±ã
ã³ããå ¬ç¥ã®æ¹æ³ã§ãªãã·ã åïŒããããã·ã€ã
ãåïŒããããšã«ããåŸãããããªãã·ã åã«äœ¿
çšãããããããã·ã«ã¢ãã³ã¯éé¢ã®åœ¢ã§ãå¡©é ž
å¡©ã®åœ¢ã§ã䜿çšããããããããã·ã«ã¢ãã³ã®äœ¿
çšéã¯ïŒïŒã«å¯ŸããŠïŒã20åœéã§ããã åå¿ã¯ãã¡ã¿ããŒã«ããšã¿ããŒã«çã®ã¢ã«ã³ãŒ
ã«ç³»æº¶åªïŒãžã¡ãã«ãã«ã ã¢ãããâã¡ãã«â
ïŒâãããªãžãã³çã®ã¢ãã系溶åªïŒãžã¡ãã«ã¹
ã«ããã·ãçã®ã¹ã«ããã·ã系溶åªïŒããã©ãã
ããã©ã³ããžãªããµã³çã®ãšãŒãã«ç³»æº¶åªïŒããª
ãžã³ãããªãšãã«ã¢ãã³çã®å¡©åºæ§æº¶åªãæ°Žäžã§
è¡ãªããããããããã¯ãããã®ïŒçš®ä»¥äžã®æº¶åª
ã®æ··åç©ãçšããããã ããããã·ã«ã¢ãã³ãå¡©é žå¡©ã®åœ¢ã§äœ¿çšããå Ž
åã«ã¯ãéåžžãããšåœé以äžã®ããªãžã³ãããªãš
ãã«ã¢ãã³çã®ç¬¬ïŒçŽã¢ãã³é¡ãããããã¯æ°Žé ž
åãããªãŠã ãæ°Žé žåã«ãªãŠã ãçé žã«ãªãŠã ã
çé žãããªãŠã çã®ç¡æ©å¡©é¡ãšäžèšæº¶åªäžã«æ·»å
ããŠåå¿ãè¡ãªãããã åå¿æž©åºŠã¯ãâ20âã
150âã奜ãŸããã¯ïŒâã100âã§ããã äžè¿°ã®ãªãã·ã ååå¿ã«ãããç°æ§äœããã³
ç°æ§äœã®ïŒçš®ãçæããããæ¬çºæã«ãããŠ
ã¯ãïŒçš®ã®ç°æ§äœã®æ··åç©ã®åœ¢ã§ãããããã¯å
ç°æ§äœã«åé¢ããåŸãåäžã®ç°æ§äœã®åœ¢ã§ãã
ãã éåžžã¯åå¿åŸãäžè¬åŒïŒïŒã§è¡šãããããšã¿
ãã³ãªãã·ã é¡ãéé¢å¡©åºã®åœ¢ã§åãåºããåŸã
åçµæ¶æ³ãã«ã©ã ã¯ãããæ³çæ £çšã®æ段ãçšã
ãŠãããããåäžã®ç°æ§äœãåŸãããšãã§ããã
ææã«ãããäžè¬åŒïŒïŒã®ãšã¿ãã³ãªãã·ã é¡
ããæãŸããé žãšæ¥è§Šãããããšã«ãããé žä»å
å¡©ã®åœ¢ã§åŸãããšãã§ããã äžèšåå¿ã®åæã§ããäžè¬åŒïŒïŒã§ç€ºããã
ã¢ããã±ãã³é¡ã¯äžèšã®åæ¹æ³ã§è£œé ããããšã
ã§ããã ïŒäžèšåŒäžã®R1ãR2ãR3ã¯ãäžèšäžè¬åŒïŒïŒ
äžã§å®çŸ©ãããšããã§ãããã¯å¡©çŽ ååçã®ã
ãã²ã³ååãè¡šãããïŒ äžè¬åŒïŒïŒã§è¡šããããαâããã¢ã»ãããš
ãã³é¡ãšäžè¬åŒïŒïŒã§è¡šããããã¢ãã³é¡ãå
å¿ãããããšã«ãããäžè¬åŒïŒïŒã§è¡šãããã
ã¢ããã±ãã³é¡ãåŸãããšãã§ããããã®ã¢ãã
ååå¿ã«ãããã¢ãã³é¡ã®äœ¿çšéã¯ïŒïŒã«å¯Ÿã
éåžžåœã¢ã«ä»¥äžã§ããã åå¿ã¯ç¡æº¶åªã§ãé²è¡ãããããžãªããµã³ãã
ãã©ããããã©ã³çã®ãšãŒãã«ç³»æº¶åªïŒãžã¡ãã«
ãã«ã ã¢ãããâã¡ãã«âïŒâãããªãžãã³ç
ã®ã¢ãã系溶åªïŒã¡ã¿ããŒã«ããšã¿ããŒã«çã®ã¢
ã«ã³ãŒã«ç³»æº¶åªïŒæ°Žãããã¯ãããïŒçš®ä»¥äžã®æ··
åç©çåå¿ã«äžæŽ»æ§ãªæº¶åªã䜿çšã§ãããåå¿æž©
床ã¯ç¹ã«éå®ãããªããéåžž0°ã150âã§ããã
ãŸãåå¿ã«ããçããããã²ã³åæ°ŽçŽ ãæéããŠ
åå¿ãä¿é²ãããããã«ãå¡©åºé¡ãæ·»å ããŠãã
ããå¡©åºé¡ãšããŠã¯ãæ°Žé žåãããªãŠã ãæ°Žé žå
ã«ãªãŠã ãçé žãããªãŠã ãçé žã«ãªãŠã çã®ç¡
æ©å¡©åºé¡ïŒããªãžã³ãããªãšãã«ã¢ãã³çã®ç¬¬ïŒ
çŽã¢ãã³é¡ã䜿çšããããå¡©åºé¡ã®äœ¿çšéã¯éåžž
ïŒïŒã«å¯Ÿãåœã¢ã«ä»¥äžã§ãããç®çç©ã§ããã¢
ããã±ãã³é¡ïŒïŒã¯ãåå¿æ¡ä»¶ã«ããéé¢å¡©åº
ã®åœ¢ãããã¯ããã²ã³åæ°ŽçŽ ãšã®é žä»å å¡©ã®åœ¢ã®
ãããããææãã圢ã§åŸãããã æ¬åå¿ã¯ãé«åçã§é²è¡ãããããåŸãããã¢
ããã±ãã³é¡ïŒïŒã¯ç²Ÿè£œãè¡ãªããã«å ã«è¿°ã¹
ããªãã·ã ååå¿ã«äœ¿çšã§ããããããã¯ãçæ
ããã¢ããã±ãã³é¡ïŒïŒã®åå¿æ··åç©ã«ããã
ãã·ã«ã¢ãã³ãæ·»å ããããšã«ãããé£ç¶ããŠãª
ãã·ã ååå¿ãå®æœããããšãã§ããã ïŒäžèšåŒäžã®R3ã¯äžè¬åŒïŒïŒã§å®çŸ©ãããš
ããã§ãããR6ã¯ã€ãããŸãŒã«âïŒâã€ã«åºã
ïŒâã¡ãã«ã€ãããŸãŒã«âïŒâã€ã«åºãïŒâãã
ãªãžãåºãïŒâã¡ãã«âïŒâããã©ãžãåºã
ãåŒãïŒR7ïŒâOMeãâCH3ãâClïŒ
ãè¡šãããïŒ
äžè¬åŒïŒïŒã§è¡šããããååç©ã®äžã§ãäžè¬
åŒïŒïŒã§è¡šããããååç©ã¯ãäžè¬åŒïŒïŒã§
è¡šããããããªãŒã«é¡ãããã¯ïŒçŽã¢ãã³é¡ãšäž
è¬åŒïŒïŒã§è¡šãããããã«ãªãäœãšãåå¿ãã
ãããšã«ããåŸããããåå¿æ¡ä»¶ãšããŠã¯äžèšã®
ïŒçš®é¡ã®æ¹æ³ããéžæã§ããã 第ïŒçªç®ã®æ¹æ³ã¯ããžã¡ãã«ãã«ã ã¢ããã
âã¡ãã«âïŒâãããªãžãã³çã®ã¢ãã系溶åªäž
ã§ïŒïŒãšïŒïŒãšããçé žã«ãªãŠã çã®ç¡æ©å¡©
é¡ãšé ç²çã®é 觊åªã®ååšäžåå¿ããããã®ã§ã
ããåå¿æž©åºŠã¯ãéåžž60ã120âã§ãããïŒïŒ
ã¯ãïŒïŒã«å¯Ÿããéåžžçã¢ã«ä»¥äžäœ¿çšãããç
é žã«ãªãŠã çã®ç¡æ©å¡©åºã¯ãïŒïŒã«å¯ŸããŠ0.5å
ã¢ã«ä»¥äžäœ¿çšããã奜ãŸããã¯ãïŒã¢ã«ããïŒå
ã¢ã«ã®éãçšãããé 觊åªã¯ïŒïŒã«å¯Ÿãéåžž
0.1ããïŒééïŒ ã®éãçšããã 次ã«ç¬¬ïŒçªç®ã®æ¹æ³ã¯ãïŒïŒãšïŒïŒãšãã
æ°Žé žåãããªãŠã ã®ååšäžãžã¡ãã«ã¹ã«ããã·ã
çã®äžæŽ»æ§æº¶åªäžã§åå¿ãããæ¹æ³ã§ããã ïŒïŒã¯ïŒïŒã«å¯Ÿãéåžžçã¢ã«ä»¥äžäœ¿çšã
ããæ°ŽçŽ åãããªãŠã ã¯éåžžïŒïŒã®ïŒããïŒå
ã¢ã«äœ¿çšãããåå¿æž©åºŠã¯éåžžã宀枩ãã120â
ã§ããã åæã§ããïŒïŒã¯ãïŒâãã«ãªãâαâãã
ãŒã¢ã»ãããšãã³ã«ïŒïŒã§è¡šãããã¢ãã³é¡ã
ïŒæ¹æ³âïŒïŒã«èšèŒããæ¹æ³ã§åå¿ãããããšã«
ããåŸãããã ïŒäžèšåŒäžã®R3ã¯äžè¬åŒïŒïŒã§å®çŸ©ãããš
ããã§ãããR7ã¯ããšãã«åºãããªã«åºãè¡šã
ããïŒäžè¬åŒïŒïŒã§è¡šããããååç©ã®äžã§ã
äžè¬åŒïŒïŒã§è¡šããããååç©ã¯ãäžè¬åŒ
ïŒïŒã®ã¹ã«ããã«ã¯ããªãé¡ãšãäžè¬åŒïŒïŒ
ã®ã¢ããªã³é¡ãšãåžžæ³ã«ããåå¿ãããããšã«ã
ãåŸããããããªãã¡ã¢ããªã³é¡ïŒïŒãããªãž
ã³ã«æº¶è§£ãããæ°·å·äžã§ã¹ã«ããã«ã¯ããªãé¡
ïŒïŒãæ·»å ããããšã«ããå®æœã§ããã åæã§ããã¢ããªã³é¡ïŒïŒã¯ãïŒâã¢ã»ãã«
ã¢ããâαâããã¢ã»ãããšãã³ã«ïŒïŒãïŒæ¹
æ³âïŒïŒã«èšèŒããæ¹æ³ã§åå¿ãããåžžæ³ã«ãã
å æ°Žå解ããããšã«ããåŸãããã ïŒæ¹æ³âïŒïŒã®åºçºåæã§ãããäžè¬åŒïŒïŒ
ã§è¡šããããαâããã¢ã»ãããšãã³é¡ã¯ãR1
åã³R2ã®æ§è³ªã«ããäžèšã®ããããã®æ¹æ³ã§è£œ
é ã§ããã (A) è³éŠæååç©ã®ããã¢ã»ãã«ãã©ã€ãã«ãã
ããªãŒãã«ã»ã¯ã©ããåå¿ ïŒG.CavarriniãJ.Med.Chem.ïŒïŒïŒ573â578
ïŒ1963ïŒïŒã«èšèŒã®æ¹æ³ã«æºããŠè¡ãªããããå®æœ
äŸïŒã19ã«èšèŒã®Î±âããã¢ã»ãããšãã³é¡ã (B) αâããã¢ã»ãããšãã³é¡ã§ã®å€æ ïœ ã¹ã«ãã€ãã®ã¹ã«ããã·ããžã®é žå ïŒG.CavarriniãJ.Med.Chem.ïŒïŒïŒ573â
578ïŒ1963ïŒïŒã«èšèŒã®æ¹æ³ã«æºããŠè¡ãªãã
ããå®æœäŸ20ã«èšèŒã®Î±âããã¢ã»ãããšã
ã³ã ïœ ïŒ®âã¢ã»ãã«äœã®å æ°Žå解 å®æœäŸ21ïŒ22ã«èšèŒã®Î±âããã¢ã»ãããš
ãã³é¡ã (C) ã¢ã»ãããšãã³é¡ã®Î±âããã²ã³ååå¿ å®æœäŸ33ã44ã«èšèŒã®Î±âããã¢ã»ãããšãã³
é¡ã äžèš(C)ã®åºçºåæã§ãããã¢ã»ãããšãã³é¡
ã¯ãå®æœäŸ35ã«èšèŒããã°ãªãã€ãŒã«è©Šè¬ãšç¡æ°Ž
é ¢é žã®åå¿ããå®æœäŸ34ã«èšèŒãããããšããŒã«
ã¢ã»ãã«ãšã¹ãã«ã®ããªãŒã¹è»¢äœçãå ¬ç¥ã®æ¹æ³
ã§è£œé ã§ããã æ¬çºæååç©ã®ãšã¿ãã³ãªãã·ã é¡ããã³ãã®
é žä»å å¡©ã®è¬çå¹æã«ã€ããŠã¹ãã¬ã¹æœ°çæå¶è©Š
éšã®çµæã«åºã¥ããŠèª¬æãããã¹ãã¬ã¹æœ°çæå¶
è©Šè¬ã¯ä»¥äžã®ãšããã«ããŠè¡ãªã€ãã äžçŸ€ïŒå¹ã®é絶é£Douryuç³»éæ§ã©ããïŒéå
åãäœé220â250gïŒãé網ã¹ãã¬ã¹ã±ãŒãžã«å ¥
ãã22±ïŒâã®æ°Žæ§œå ã«å£ç¶éªšã®æ·±ããŸã§æµžãã
ã¹ãã¬ã¹ãè² è·ããã15æéåŸã«ãã©ãããæ²æ®º
ããŠèãæåºãèå ã«ïŒïŒ ãã«ããªã³çŽ15mlã泚
å ¥åŸãïŒïŒ ãã«ããªã³æ¶²ã«10åé浞ããŠåºå®ã
ããåºå®åŸã倧匯ã«æ²¿ã€ãŠèãåãéããè ºèéš
ã«çºçãã朰çã®é·åŸããå®äœé¡åŸ®é¡äžïŒX10ïŒ
ã§æž¬å®ãããã®åèšã朰çä¿æ°ïŒmmïŒãšãããè¬
ç©ã¯ïŒïŒ ã¢ã©ãã¢ãŽã 液ã«æžæ¿ãããïŒmlïŒKgã®
çšéãã¹ãã¬ã¹è² è·30ååã«çµå£æäžãããå¯Ÿç §
矀ã«ã¯ïŒïŒ ã¢ã©ãã¢ãŽã 液ãæäžãããã®æœ°çä¿
æ°ã被æ€è¬ç©æäžçŸ€ã®æœ°çä¿æ°ãšæ¯èŒãã被æ€è¬
ç©ã®æå¶çãç®åºããããªããæäžéã¯åååç©
ãšã50mgïŒKgã§ãã€ãã è©Šéšçµæãäžèšè¡šâïŒã«ç€ºãããªããè¡šäžã®è©Š
éšååç©ã¯ãå®æœäŸçªå·ã§ç€ºãã
åŒïŒïŒã§è¡šããããååç©ã¯ãäžè¬åŒïŒïŒã§
è¡šããããããªãŒã«é¡ãããã¯ïŒçŽã¢ãã³é¡ãšäž
è¬åŒïŒïŒã§è¡šãããããã«ãªãäœãšãåå¿ãã
ãããšã«ããåŸããããåå¿æ¡ä»¶ãšããŠã¯äžèšã®
ïŒçš®é¡ã®æ¹æ³ããéžæã§ããã 第ïŒçªç®ã®æ¹æ³ã¯ããžã¡ãã«ãã«ã ã¢ããã
âã¡ãã«âïŒâãããªãžãã³çã®ã¢ãã系溶åªäž
ã§ïŒïŒãšïŒïŒãšããçé žã«ãªãŠã çã®ç¡æ©å¡©
é¡ãšé ç²çã®é 觊åªã®ååšäžåå¿ããããã®ã§ã
ããåå¿æž©åºŠã¯ãéåžž60ã120âã§ãããïŒïŒ
ã¯ãïŒïŒã«å¯Ÿããéåžžçã¢ã«ä»¥äžäœ¿çšãããç
é žã«ãªãŠã çã®ç¡æ©å¡©åºã¯ãïŒïŒã«å¯ŸããŠ0.5å
ã¢ã«ä»¥äžäœ¿çšããã奜ãŸããã¯ãïŒã¢ã«ããïŒå
ã¢ã«ã®éãçšãããé 觊åªã¯ïŒïŒã«å¯Ÿãéåžž
0.1ããïŒééïŒ ã®éãçšããã 次ã«ç¬¬ïŒçªç®ã®æ¹æ³ã¯ãïŒïŒãšïŒïŒãšãã
æ°Žé žåãããªãŠã ã®ååšäžãžã¡ãã«ã¹ã«ããã·ã
çã®äžæŽ»æ§æº¶åªäžã§åå¿ãããæ¹æ³ã§ããã ïŒïŒã¯ïŒïŒã«å¯Ÿãéåžžçã¢ã«ä»¥äžäœ¿çšã
ããæ°ŽçŽ åãããªãŠã ã¯éåžžïŒïŒã®ïŒããïŒå
ã¢ã«äœ¿çšãããåå¿æž©åºŠã¯éåžžã宀枩ãã120â
ã§ããã åæã§ããïŒïŒã¯ãïŒâãã«ãªãâαâãã
ãŒã¢ã»ãããšãã³ã«ïŒïŒã§è¡šãããã¢ãã³é¡ã
ïŒæ¹æ³âïŒïŒã«èšèŒããæ¹æ³ã§åå¿ãããããšã«
ããåŸãããã ïŒäžèšåŒäžã®R3ã¯äžè¬åŒïŒïŒã§å®çŸ©ãããš
ããã§ãããR7ã¯ããšãã«åºãããªã«åºãè¡šã
ããïŒäžè¬åŒïŒïŒã§è¡šããããååç©ã®äžã§ã
äžè¬åŒïŒïŒã§è¡šããããååç©ã¯ãäžè¬åŒ
ïŒïŒã®ã¹ã«ããã«ã¯ããªãé¡ãšãäžè¬åŒïŒïŒ
ã®ã¢ããªã³é¡ãšãåžžæ³ã«ããåå¿ãããããšã«ã
ãåŸããããããªãã¡ã¢ããªã³é¡ïŒïŒãããªãž
ã³ã«æº¶è§£ãããæ°·å·äžã§ã¹ã«ããã«ã¯ããªãé¡
ïŒïŒãæ·»å ããããšã«ããå®æœã§ããã åæã§ããã¢ããªã³é¡ïŒïŒã¯ãïŒâã¢ã»ãã«
ã¢ããâαâããã¢ã»ãããšãã³ã«ïŒïŒãïŒæ¹
æ³âïŒïŒã«èšèŒããæ¹æ³ã§åå¿ãããåžžæ³ã«ãã
å æ°Žå解ããããšã«ããåŸãããã ïŒæ¹æ³âïŒïŒã®åºçºåæã§ãããäžè¬åŒïŒïŒ
ã§è¡šããããαâããã¢ã»ãããšãã³é¡ã¯ãR1
åã³R2ã®æ§è³ªã«ããäžèšã®ããããã®æ¹æ³ã§è£œ
é ã§ããã (A) è³éŠæååç©ã®ããã¢ã»ãã«ãã©ã€ãã«ãã
ããªãŒãã«ã»ã¯ã©ããåå¿ ïŒG.CavarriniãJ.Med.Chem.ïŒïŒïŒ573â578
ïŒ1963ïŒïŒã«èšèŒã®æ¹æ³ã«æºããŠè¡ãªããããå®æœ
äŸïŒã19ã«èšèŒã®Î±âããã¢ã»ãããšãã³é¡ã (B) αâããã¢ã»ãããšãã³é¡ã§ã®å€æ ïœ ã¹ã«ãã€ãã®ã¹ã«ããã·ããžã®é žå ïŒG.CavarriniãJ.Med.Chem.ïŒïŒïŒ573â
578ïŒ1963ïŒïŒã«èšèŒã®æ¹æ³ã«æºããŠè¡ãªãã
ããå®æœäŸ20ã«èšèŒã®Î±âããã¢ã»ãããšã
ã³ã ïœ ïŒ®âã¢ã»ãã«äœã®å æ°Žå解 å®æœäŸ21ïŒ22ã«èšèŒã®Î±âããã¢ã»ãããš
ãã³é¡ã (C) ã¢ã»ãããšãã³é¡ã®Î±âããã²ã³ååå¿ å®æœäŸ33ã44ã«èšèŒã®Î±âããã¢ã»ãããšãã³
é¡ã äžèš(C)ã®åºçºåæã§ãããã¢ã»ãããšãã³é¡
ã¯ãå®æœäŸ35ã«èšèŒããã°ãªãã€ãŒã«è©Šè¬ãšç¡æ°Ž
é ¢é žã®åå¿ããå®æœäŸ34ã«èšèŒãããããšããŒã«
ã¢ã»ãã«ãšã¹ãã«ã®ããªãŒã¹è»¢äœçãå ¬ç¥ã®æ¹æ³
ã§è£œé ã§ããã æ¬çºæååç©ã®ãšã¿ãã³ãªãã·ã é¡ããã³ãã®
é žä»å å¡©ã®è¬çå¹æã«ã€ããŠã¹ãã¬ã¹æœ°çæå¶è©Š
éšã®çµæã«åºã¥ããŠèª¬æãããã¹ãã¬ã¹æœ°çæå¶
è©Šè¬ã¯ä»¥äžã®ãšããã«ããŠè¡ãªã€ãã äžçŸ€ïŒå¹ã®é絶é£Douryuç³»éæ§ã©ããïŒéå
åãäœé220â250gïŒãé網ã¹ãã¬ã¹ã±ãŒãžã«å ¥
ãã22±ïŒâã®æ°Žæ§œå ã«å£ç¶éªšã®æ·±ããŸã§æµžãã
ã¹ãã¬ã¹ãè² è·ããã15æéåŸã«ãã©ãããæ²æ®º
ããŠèãæåºãèå ã«ïŒïŒ ãã«ããªã³çŽ15mlã泚
å ¥åŸãïŒïŒ ãã«ããªã³æ¶²ã«10åé浞ããŠåºå®ã
ããåºå®åŸã倧匯ã«æ²¿ã€ãŠèãåãéããè ºèéš
ã«çºçãã朰çã®é·åŸããå®äœé¡åŸ®é¡äžïŒX10ïŒ
ã§æž¬å®ãããã®åèšã朰çä¿æ°ïŒmmïŒãšãããè¬
ç©ã¯ïŒïŒ ã¢ã©ãã¢ãŽã 液ã«æžæ¿ãããïŒmlïŒKgã®
çšéãã¹ãã¬ã¹è² è·30ååã«çµå£æäžãããå¯Ÿç §
矀ã«ã¯ïŒïŒ ã¢ã©ãã¢ãŽã 液ãæäžãããã®æœ°çä¿
æ°ã被æ€è¬ç©æäžçŸ€ã®æœ°çä¿æ°ãšæ¯èŒãã被æ€è¬
ç©ã®æå¶çãç®åºããããªããæäžéã¯åååç©
ãšã50mgïŒKgã§ãã€ãã è©Šéšçµæãäžèšè¡šâïŒã«ç€ºãããªããè¡šäžã®è©Š
éšååç©ã¯ãå®æœäŸçªå·ã§ç€ºãã
ãè¡šã
ïŒ å¡©é
žå¡©äœãè©Šéš
ïŒïŒ 200mgïŒKgã»P.O.
äžèšè©Šéšçµæããæãããªããã«ãæ¬çºæã®ãš
ã¿ãã³ãªãã·ã é¡ããã³ãã®é žä»å å¡©ã¯æ朰çè¬
ãšããŠæçšã§ããã æ²»ççšãšããŠãæ¬çºæã®ãšã¿ãã³ãªãã·ã é¡ã
ãã³ãã®é žä»å å¡©ã¯ãããªãæ¹æ³ã§ãæäžã§ã
ãã ããªãã¡ç®äžæ³šå°ãéèå 泚å°ãçè泚å°ãè ¹
è å 泚å°çã®éçµå£æäžããŸãçµå£æäžãå¯èœã§
ããã æäžéã¯æ£è ã®å¹Žä»€ãå¥åº·ç¶æ ãäœéã朰çç¶
æ ã®çšåºŠãåæåŠçããããªãã°ãã®çš®é¡ãåŠçœ®
é »åºŠãææã®å¹æã®æ§è³ªçã«ãã決å®ãããã äžè¬çã«æå¹æåã®ïŒæ¥æäžéã¯0.1ã10mgïŒ
Kgäœéãéåžž0.3ãïŒmgïŒKgäœéã§ãããïŒåã
ããã¯ãã以äžæäžãããã æ¬çºæååç©ãçµå£æäžããå Žåã¯é å€ãã«ã
ã»ã«å€ãç²å€ã液å€ããšãªãã·ã«å€çã®å€åœ¢ã§ã
ãŸãéçµå£æäžã®å Žåã¯æ¶²äœãããã¯æžæ¿çã®æ®º
èãã液ç¶ã®åœ¢ã§çšãããããäžè¿°ã®æ§ãªå€åœ¢ã§
çšããããå Žåãåºäœãããã¯æ¶²äœã®æ¯æ§ã®ãªã
補å€çæ äœãçµæã«å«ãŸãåŸãã åºäœæ äœã®äŸãšããŠã¯éåžžã®ãŒã©ãã³ã¿ã€ãã®
ã«ãã»ã«ãçšããããããŸãæå¹æåãè£å©è¬ãš
ãšãã«ãããã¯ãããªãã«é å€åãç²æ«å è£ ãã
ãã ãããã®ã«ãã»ã«ãé å€ãç²æ«ã¯äžè¬çã«ïŒã
95ïŒ ã奜ãŸããã¯25ã90ïŒ ééã®æå¹æåãå«
ãã ããªãã¡ãããã®æäžåœ¢åŒã§ã¯ïŒã500mgã奜
ãŸããã¯ïŒã100mgã®æå¹æåãå«æããã®ãã
ãã 液ç¶æ äœãšããŠã¯ãããã¯ç³æ²¹ãããŒããæ²¹ã
倧è±æ²¹ãããã©ã«æ²¹ããŽãæ²¹çã®åæ€ç©èµ·åã®ã
ãŸãã¯åæã®æ²¹çãçšããããã ãŸããäžè¬ã«ççé£å¡©æ°Žãããã¹ãããŒã¹ãã
ãã¯é¡äŒŒã®ã·ãšç³æº¶æ¶²ããšãã¬ã³ã°ãªã³ãŒã«ãã
ããã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ç
ã®ã°ãªã³ãŒã«é¡ã液ç¶æ äœãšããŠå¥œãŸããããšã
ã«ççé£å¡©æ°Žãçšãã泚å°æ¶²ã®å Žåã«ã¯éåžž0.5
ã20ïŒ ã奜ãŸããã¯ïŒã10ïŒ ééã®æå¹æåãå«
ãããã«ããã çµå£æäžã®æ¶²å€ã®å Žåã0.5ã10ïŒ ééã®æå¹
æåãå«ãæžæ¿æ¶²ãããã¯ã·ããããããã ãã®å Žåã®æ äœãšããŠã¯éŠæãã·ãããã補å€
åŠçãã»ã«äœçã®æ°Žæ§è³Šåœ¢å€ãçšããã ãçºæã®å¹æã 以äžè©³çŽ°ããããã«ãæ¬çºæã®ãšã¿ãã³ãªãã·
ã é¡ããã³ãã®é žä»å å¡©ã¯æ°èŠååç©ã§ãã€ãŠã
æ朰çè¬ãšããŠæçšã§ããã ãå®æœäŸã 以äžãå®æœäŸã«ããæ¬çºæãå ·äœçã«èª¬æãã
ããæ¬çºæã¯ãã®èŠæšãè¶ããªãéãã以äžã®å®
æœäŸã«ãã€ãŠéå®ããããã®ã§ã¯ãªãã å®æœäŸ ïŒ ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâããšãã«ããªâããšãã«ïŒâãšã¿ãã³ãªã
ã·ã ïŒâã¯ããã¢ã»ãã«ãžããšãã«ã¹ã«ãã€ã
10.0gãã¡ã¿ããŒã«50mlã«æº¶è§£åŸãâã¡ãã«ã
ãã©ãžã³7.7gãå ãã宀枩ã§ïŒæéãéæµäžïŒæ
éæªæããã宀枩ãŸã§å·åŽåŸãããããã·ã«ã¢ã
ã³å¡©é žå¡©5.3ïœãå ãïŒæéæªæåŸãïŒå€æŸçœ®ã
ãããã®åŸåå¿æ¶²ã也åºããå·åŽäžæ®æž£ã«ã¯ãã
ãã«ã ã飜åçé žã«ãªãŠã 氎溶液ãå ããŠå液ã
ããææ©å±€ãæ°ŽæŽåŸãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥
ã也åºããããšã«ããç°æ§äœãç°æ§äœã®æ··å
ç©ãåŸãã次ã«ãã®æ··åç©ã溶é¢æ¶²ãšããŠã¯ãã
ãã«ã ïŒã¡ã¿ããŒã«ïŒ97ïŒïŒïŒãçšããŠã·ãªã«ã²
ã«ã«ã©ã ã¯ãããã°ã©ãã€ãŒã«ããåé¢åŸããšã¿
ããŒã«ããããããåçµæ¶ãããããšã«ãããè
ç¹189â190âã®ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãž
ã³âïŒâã€ã«ïŒâïŒâïŒïŒâããšãã«ããªâããšã
ã«ïŒâãšã¿ãã³ãªãã·ã 6.6gãšèç¹168â169âã®
ïŒïŒ¥ïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâ
ïŒâïŒïŒâããšãã«ããªâããšãã«ïŒâãšã¿ãã³ãª
ãã·ã 2.5gãåŸãã æŽã«é žä»å ã¯ä»¥äžã®ããã«å®æœããã ç°æ§äœ3.0gããšã¿ããŒã«180mlã«å ç±æº¶è§£ãã
å·åŽåŸã宀枩æªæäž30ïŒ å¡©é žâãšã¿ããŒã«1.1ml
ãå ããã ãã®åŸãšã¿ããŒã«ãçŽ1/2ãŸã§æžå§äžæ¿çž®ãã
æ°·å·ã§ïŒæéæªæãããæåºçµæ¶ãåã也ç¥
ããèç¹217â219âïŒå解ïŒã®ïŒïŒºïŒâïŒâïŒïŒâ
ã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâããšã
ã«ããªâããšãã«ïŒâãšã¿ãã³ãªãã·ã å¡©é žå¡©
3.1gãåŸãã å®æœäŸïŒãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ïŒïŒ 200mgïŒKgã»P.O.
äžèšè©Šéšçµæããæãããªããã«ãæ¬çºæã®ãš
ã¿ãã³ãªãã·ã é¡ããã³ãã®é žä»å å¡©ã¯æ朰çè¬
ãšããŠæçšã§ããã æ²»ççšãšããŠãæ¬çºæã®ãšã¿ãã³ãªãã·ã é¡ã
ãã³ãã®é žä»å å¡©ã¯ãããªãæ¹æ³ã§ãæäžã§ã
ãã ããªãã¡ç®äžæ³šå°ãéèå 泚å°ãçè泚å°ãè ¹
è å 泚å°çã®éçµå£æäžããŸãçµå£æäžãå¯èœã§
ããã æäžéã¯æ£è ã®å¹Žä»€ãå¥åº·ç¶æ ãäœéã朰çç¶
æ ã®çšåºŠãåæåŠçããããªãã°ãã®çš®é¡ãåŠçœ®
é »åºŠãææã®å¹æã®æ§è³ªçã«ãã決å®ãããã äžè¬çã«æå¹æåã®ïŒæ¥æäžéã¯0.1ã10mgïŒ
Kgäœéãéåžž0.3ãïŒmgïŒKgäœéã§ãããïŒåã
ããã¯ãã以äžæäžãããã æ¬çºæååç©ãçµå£æäžããå Žåã¯é å€ãã«ã
ã»ã«å€ãç²å€ã液å€ããšãªãã·ã«å€çã®å€åœ¢ã§ã
ãŸãéçµå£æäžã®å Žåã¯æ¶²äœãããã¯æžæ¿çã®æ®º
èãã液ç¶ã®åœ¢ã§çšãããããäžè¿°ã®æ§ãªå€åœ¢ã§
çšããããå Žåãåºäœãããã¯æ¶²äœã®æ¯æ§ã®ãªã
補å€çæ äœãçµæã«å«ãŸãåŸãã åºäœæ äœã®äŸãšããŠã¯éåžžã®ãŒã©ãã³ã¿ã€ãã®
ã«ãã»ã«ãçšããããããŸãæå¹æåãè£å©è¬ãš
ãšãã«ãããã¯ãããªãã«é å€åãç²æ«å è£ ãã
ãã ãããã®ã«ãã»ã«ãé å€ãç²æ«ã¯äžè¬çã«ïŒã
95ïŒ ã奜ãŸããã¯25ã90ïŒ ééã®æå¹æåãå«
ãã ããªãã¡ãããã®æäžåœ¢åŒã§ã¯ïŒã500mgã奜
ãŸããã¯ïŒã100mgã®æå¹æåãå«æããã®ãã
ãã 液ç¶æ äœãšããŠã¯ãããã¯ç³æ²¹ãããŒããæ²¹ã
倧è±æ²¹ãããã©ã«æ²¹ããŽãæ²¹çã®åæ€ç©èµ·åã®ã
ãŸãã¯åæã®æ²¹çãçšããããã ãŸããäžè¬ã«ççé£å¡©æ°Žãããã¹ãããŒã¹ãã
ãã¯é¡äŒŒã®ã·ãšç³æº¶æ¶²ããšãã¬ã³ã°ãªã³ãŒã«ãã
ããã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ç
ã®ã°ãªã³ãŒã«é¡ã液ç¶æ äœãšããŠå¥œãŸããããšã
ã«ççé£å¡©æ°Žãçšãã泚å°æ¶²ã®å Žåã«ã¯éåžž0.5
ã20ïŒ ã奜ãŸããã¯ïŒã10ïŒ ééã®æå¹æåãå«
ãããã«ããã çµå£æäžã®æ¶²å€ã®å Žåã0.5ã10ïŒ ééã®æå¹
æåãå«ãæžæ¿æ¶²ãããã¯ã·ããããããã ãã®å Žåã®æ äœãšããŠã¯éŠæãã·ãããã補å€
åŠçãã»ã«äœçã®æ°Žæ§è³Šåœ¢å€ãçšããã ãçºæã®å¹æã 以äžè©³çŽ°ããããã«ãæ¬çºæã®ãšã¿ãã³ãªãã·
ã é¡ããã³ãã®é žä»å å¡©ã¯æ°èŠååç©ã§ãã€ãŠã
æ朰çè¬ãšããŠæçšã§ããã ãå®æœäŸã 以äžãå®æœäŸã«ããæ¬çºæãå ·äœçã«èª¬æãã
ããæ¬çºæã¯ãã®èŠæšãè¶ããªãéãã以äžã®å®
æœäŸã«ãã€ãŠéå®ããããã®ã§ã¯ãªãã å®æœäŸ ïŒ ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâããšãã«ããªâããšãã«ïŒâãšã¿ãã³ãªã
ã·ã ïŒâã¯ããã¢ã»ãã«ãžããšãã«ã¹ã«ãã€ã
10.0gãã¡ã¿ããŒã«50mlã«æº¶è§£åŸãâã¡ãã«ã
ãã©ãžã³7.7gãå ãã宀枩ã§ïŒæéãéæµäžïŒæ
éæªæããã宀枩ãŸã§å·åŽåŸãããããã·ã«ã¢ã
ã³å¡©é žå¡©5.3ïœãå ãïŒæéæªæåŸãïŒå€æŸçœ®ã
ãããã®åŸåå¿æ¶²ã也åºããå·åŽäžæ®æž£ã«ã¯ãã
ãã«ã ã飜åçé žã«ãªãŠã 氎溶液ãå ããŠå液ã
ããææ©å±€ãæ°ŽæŽåŸãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥
ã也åºããããšã«ããç°æ§äœãç°æ§äœã®æ··å
ç©ãåŸãã次ã«ãã®æ··åç©ã溶é¢æ¶²ãšããŠã¯ãã
ãã«ã ïŒã¡ã¿ããŒã«ïŒ97ïŒïŒïŒãçšããŠã·ãªã«ã²
ã«ã«ã©ã ã¯ãããã°ã©ãã€ãŒã«ããåé¢åŸããšã¿
ããŒã«ããããããåçµæ¶ãããããšã«ãããè
ç¹189â190âã®ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãž
ã³âïŒâã€ã«ïŒâïŒâïŒïŒâããšãã«ããªâããšã
ã«ïŒâãšã¿ãã³ãªãã·ã 6.6gãšèç¹168â169âã®
ïŒïŒ¥ïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâ
ïŒâïŒïŒâããšãã«ããªâããšãã«ïŒâãšã¿ãã³ãª
ãã·ã 2.5gãåŸãã æŽã«é žä»å ã¯ä»¥äžã®ããã«å®æœããã ç°æ§äœ3.0gããšã¿ããŒã«180mlã«å ç±æº¶è§£ãã
å·åŽåŸã宀枩æªæäž30ïŒ å¡©é žâãšã¿ããŒã«1.1ml
ãå ããã ãã®åŸãšã¿ããŒã«ãçŽ1/2ãŸã§æžå§äžæ¿çž®ãã
æ°·å·ã§ïŒæéæªæãããæåºçµæ¶ãåã也ç¥
ããèç¹217â219âïŒå解ïŒã®ïŒïŒºïŒâïŒâïŒïŒâ
ã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâããšã
ã«ããªâããšãã«ïŒâãšã¿ãã³ãªãã·ã å¡©é žå¡©
3.1gãåŸãã å®æœäŸïŒãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ãè¡šã
ãè¡šã
å®æœäŸïŒãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ãã
ãè¡šã
ãè¡šã
å®æœäŸ 20
ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâããšãã«ã¹ã«ããã«âããšã
ã«ïŒâãšã¿ãã³ãªãã·ã ïŒâã¯ããã¢ã»ãã«ãžããšãã«ã¹ã«ããã·ã
10.0gã䜿çšããå®æœäŸïŒãšåæ§ã«ããŠèç¹212â
213âã®ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒ
âã€ã«ïŒâïŒâïŒïŒâããšãã«ã¹ã«ããã«âããšã
ã«ïŒâãšã¿ãã³ãªãã·ã 6.3ïœãåŸãã å®æœäŸ 21 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâããšãã«ã¢ããâããšãã«ïŒâ
ãšã¿ãã³ãªãã·ã ïŒâã¯ããâïŒâïŒïŒâïŒïŒ®âã¢ã»ãã«ââã
ãšãã«âã¢ããïŒâããšãã«ïŒâãšã¿ãã³10.0gã
é ¢é ž100mlã«æº¶è§£åŸãæ¿å¡©é ž40mlãå ãçªçŽ é°å²
æ°æªæäžãïŒæéå ç±éæµããããå·åŽåŸãåå¿
液ãæ°Žã«ãããæåºçµæ¶ãåãæ°ŽæŽã也ç¥ãã
ïŒâã¯ããâïŒâïŒïŒâããšãã«ã¢ããâããšã
ã«ïŒâãšã¿ãã³6.5gãåŸãã次ã«ããã®ã¯ããäœ
6.5gã䜿çšããŠã以äžå®æœäŸïŒãšåæ§ã«ããŠãè
ç¹196â197âã®ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãž
ã³âïŒâã€ã«ïŒâïŒâïŒïŒâããšãã«ã¢ããâããš
ãã«ïŒâãšã¿ãã³ãªãã·ã 3.3gãåŸãã å®æœäŸ21ãšåæ§ã«ããŠãäžèšå®æœäŸ23ã®ååç©
ãåæããã å®æœäŸ 22 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒããšããã¢ãžã³âïŒâã€ã«ïŒâ
ãšã¿ãã³ãªãã·ã èç¹216â218â å®æœäŸ 23 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒã€ãããŸãŒã«âïŒâã€ã«ïŒâããšã
ã«ïŒâãšã¿ãã³ãªãã·ã 50ïŒ æ²¹æ§æ°ŽçŽ åãããªãŠã 3.6gã®ãžã¡ãã«ã¹ã«
ããã·ã50mlæžæ¿æ¶²ã«ãçªçŽ é°å²æ°æªæäžã宀枩
ã§ã€ãããŸãŒã«5.2gãå ããã宀枩ã§30åæªæ
åŸããžã¡ãã«ã¹ã«ããã·ã30mlã«æº¶è§£ãããïŒâ
ïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâ
ãã«ãªãâããšãã«ïŒâãšã¿ãã³6.0gã滎äžãã
æŽã«100âã§ïŒæéæªæãããå·åŽåŸåå¿æ¶²ãæ°·
æ°Žã«ãããã¯ãããã«ã ã§æœåºæ°ŽæŽããç¡æ°Žç¡«é ž
ãããªãŠã ã§ä¹Ÿç¥åŸä¹Ÿåºãããæ®æž£ã«ã¡ã¿ããŒã«
50mlãããªãšãã«ã¢ãã³ïŒmlãå ã溶解åŸããã
ããã·ã«ã¢ãã³å¡©é žå¡©3.5gãå ããã以äžå®æœäŸ
ïŒãšåæ§ã«ããŠãèç¹199â200âã®ïŒïŒºïŒâïŒâ
ïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâ
ïŒã€ãããŸãŒã«âïŒâã€ã«ïŒâããšãã«ïŒâãšã¿ã
ã³ãªãã·ã 2.5gãåŸãã å®æœäŸ23ãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ã«ïŒâïŒâïŒïŒâããšãã«ã¹ã«ããã«âããšã
ã«ïŒâãšã¿ãã³ãªãã·ã ïŒâã¯ããã¢ã»ãã«ãžããšãã«ã¹ã«ããã·ã
10.0gã䜿çšããå®æœäŸïŒãšåæ§ã«ããŠèç¹212â
213âã®ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒ
âã€ã«ïŒâïŒâïŒïŒâããšãã«ã¹ã«ããã«âããšã
ã«ïŒâãšã¿ãã³ãªãã·ã 6.3ïœãåŸãã å®æœäŸ 21 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâããšãã«ã¢ããâããšãã«ïŒâ
ãšã¿ãã³ãªãã·ã ïŒâã¯ããâïŒâïŒïŒâïŒïŒ®âã¢ã»ãã«ââã
ãšãã«âã¢ããïŒâããšãã«ïŒâãšã¿ãã³10.0gã
é ¢é ž100mlã«æº¶è§£åŸãæ¿å¡©é ž40mlãå ãçªçŽ é°å²
æ°æªæäžãïŒæéå ç±éæµããããå·åŽåŸãåå¿
液ãæ°Žã«ãããæåºçµæ¶ãåãæ°ŽæŽã也ç¥ãã
ïŒâã¯ããâïŒâïŒïŒâããšãã«ã¢ããâããšã
ã«ïŒâãšã¿ãã³6.5gãåŸãã次ã«ããã®ã¯ããäœ
6.5gã䜿çšããŠã以äžå®æœäŸïŒãšåæ§ã«ããŠãè
ç¹196â197âã®ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãž
ã³âïŒâã€ã«ïŒâïŒâïŒïŒâããšãã«ã¢ããâããš
ãã«ïŒâãšã¿ãã³ãªãã·ã 3.3gãåŸãã å®æœäŸ21ãšåæ§ã«ããŠãäžèšå®æœäŸ23ã®ååç©
ãåæããã å®æœäŸ 22 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒããšããã¢ãžã³âïŒâã€ã«ïŒâ
ãšã¿ãã³ãªãã·ã èç¹216â218â å®æœäŸ 23 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒã€ãããŸãŒã«âïŒâã€ã«ïŒâããšã
ã«ïŒâãšã¿ãã³ãªãã·ã 50ïŒ æ²¹æ§æ°ŽçŽ åãããªãŠã 3.6gã®ãžã¡ãã«ã¹ã«
ããã·ã50mlæžæ¿æ¶²ã«ãçªçŽ é°å²æ°æªæäžã宀枩
ã§ã€ãããŸãŒã«5.2gãå ããã宀枩ã§30åæªæ
åŸããžã¡ãã«ã¹ã«ããã·ã30mlã«æº¶è§£ãããïŒâ
ïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâ
ãã«ãªãâããšãã«ïŒâãšã¿ãã³6.0gã滎äžãã
æŽã«100âã§ïŒæéæªæãããå·åŽåŸåå¿æ¶²ãæ°·
æ°Žã«ãããã¯ãããã«ã ã§æœåºæ°ŽæŽããç¡æ°Žç¡«é ž
ãããªãŠã ã§ä¹Ÿç¥åŸä¹Ÿåºãããæ®æž£ã«ã¡ã¿ããŒã«
50mlãããªãšãã«ã¢ãã³ïŒmlãå ã溶解åŸããã
ããã·ã«ã¢ãã³å¡©é žå¡©3.5gãå ããã以äžå®æœäŸ
ïŒãšåæ§ã«ããŠãèç¹199â200âã®ïŒïŒºïŒâïŒâ
ïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâ
ïŒã€ãããŸãŒã«âïŒâã€ã«ïŒâããšãã«ïŒâãšã¿ã
ã³ãªãã·ã 2.5gãåŸãã å®æœäŸ23ãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ãè¡šã
å®æœäŸ 28
ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïŒâã¡ããã·âããšãã«ããªïŒ
âããšãã«ïŒâãšã¿ãã³ãªãã·ã ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâãã«ãªãâããšãã«ïŒâãšã¿ãã³6.0gã«ïŒâ
ã¡ããã·ãã³ãŒã³ããªãŒã«5.4ïœç¡æ°Žçé žã«ãªãŠ
ã 5.3gãé ç²ïŒïŒ06gããžã¡ãã«ãã«ã ã¢ãã20
mlãå ããçªçŽ é°å²æ°äž110âã§ïŒæéæªæããã å·åŽåŸåå¿æ¶²ãæ°·æ°Žã«ãããã¯ãããã«ã ã§æœ
åºæ°ŽæŽããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸä¹Ÿåºã
ããæ®æž£ã«ã¡ã¿ããŒã«50mlãããªãšãã«ã¢ãã³ïŒ
mlãå ã溶解åŸãããããã·ã«ã¢ãã³å¡©é žå¡©3.5g
ãå ããã以äžå®æœäŸïŒãšåæ§ã«ããŠèç¹176â
178âã®ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒ
âã€ã«ïŒâïŒâïŒïŒâïŒïŒâã¡ããã·âããšãã«ã
ãªïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã 3.4gãåŸãã å®æœäŸ28ãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ã«ïŒâïŒâïŒïŒâïŒïŒâã¡ããã·âããšãã«ããªïŒ
âããšãã«ïŒâãšã¿ãã³ãªãã·ã ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâãã«ãªãâããšãã«ïŒâãšã¿ãã³6.0gã«ïŒâ
ã¡ããã·ãã³ãŒã³ããªãŒã«5.4ïœç¡æ°Žçé žã«ãªãŠ
ã 5.3gãé ç²ïŒïŒ06gããžã¡ãã«ãã«ã ã¢ãã20
mlãå ããçªçŽ é°å²æ°äž110âã§ïŒæéæªæããã å·åŽåŸåå¿æ¶²ãæ°·æ°Žã«ãããã¯ãããã«ã ã§æœ
åºæ°ŽæŽããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸä¹Ÿåºã
ããæ®æž£ã«ã¡ã¿ããŒã«50mlãããªãšãã«ã¢ãã³ïŒ
mlãå ã溶解åŸãããããã·ã«ã¢ãã³å¡©é žå¡©3.5g
ãå ããã以äžå®æœäŸïŒãšåæ§ã«ããŠèç¹176â
178âã®ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒ
âã€ã«ïŒâïŒâïŒïŒâïŒïŒâã¡ããã·âããšãã«ã
ãªïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã 3.4gãåŸãã å®æœäŸ28ãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ãè¡šã
å®æœäŸ 31
ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãã³ãŒã³ã¹ã«ããã«ã¢ããâã
ãšãã«ïŒâãšã¿ãã³ãªãã·ã å®æœäŸïŒãšåæ§ã«ããŠåŸãããïŒâïŒïŒâã¡ã
ã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâã¢ã»ãã«ã¢
ããâããšãã«ïŒâãšã¿ãã³4.0ïœã«ãšã¿ããŒã«10
mlãšæ°Ž10mlã«æº¶è§£ããæ°Žé žåãããªãŠã 1.8ïœã
å ããçªçŽ é°å²æ°äž85âã§ïŒæéæªæããããã®
åŸããšã¿ããŒã«ãçå»ãæåºæ²¹ç¶ç©ãã¯ãããã«
ã ã§æœåºæ°ŽæŽããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸä¹Ÿ
åºããïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâ
ïŒâïŒïŒâã¢ããâããšãã«ïŒâãšã¿ãã³2.7gãåŸ
ãã 次ã«ãã®ã¢ããäœ2.7gã«ããªãžã³16mlãå ãã
æ°·å·æªæäžãã³ãŒã³ã¹ã«ããã«ã¯ããªã2.1gãå
ããããã®åŸå®€æž©ã§ïŒæéæªæããåŸããããã
ã·ã«ã¢ãã³å¡©é žå¡©1.6gãå ããã以äžå®æœäŸïŒãš
åæ§ã«ããŠèç¹196â199âïŒå解ïŒã®ïŒïŒºïŒâïŒ
âïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒ
âãã³ãŒã³ã¹ã«ããã«ã¢ããâããšãã«ïŒâãšã¿
ãã³ãªãã·ã 2.2ïœãåŸãã å®æœäŸ31ãšåæ§ã«ããŠãäžèšå®æœäŸ32ã®ååç©
ãåæããã å®æœäŸ 32 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïœâãã«ãšã³ã¹ã«ããã«ã¢ã
ãïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã èç¹192â193â å®æœäŸ 33 ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâãã³ãžã«ãªãã·âããšãã«ïŒâãšã¿ãã³ãª
ãã·ã å¡©é žå¡© ïŒâãã³ãžã«ãªãã·ã¢ã»ãããšãã³4.0gãïŒïŒ
ïŒâãžãªããµã³20mlãããã©ãã€ãããã©ã³20ml
ã«æº¶è§£åŸãæ°·å·æªæäžãç¡æ°Žå¡©åã¢ã«ãããŠã
0.1gãšèçŽ 3.1gãå ãããæŽã«æ°·å·äžïŒæéæªæ
ããåŸãåå¿æ¶²ã也åºããã æ®æž£ã«ãæ°Žãšã¯ãããã«ã ãå ãå液ããã¯ã
ããã«ã å±€ãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸä¹Ÿåº
ããã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ãŒã§ã溶
é¢æ¶²ãšããŠãã³ãŒã³ïŒïœâãããµã³ïŒïŒïŒïŒïŒã
çšããŠç²Ÿè£œããïŒâããã¢âïŒâïŒïŒâãã³ãžã«
ãªãã·âããšãã«ïŒâãšã¿ãã³ãªãã·ã 4.1gãåŸ
ãã次ã«ãã®ããã¢äœ3.0gã䜿çšãã以äžå®æœäŸ
ïŒãšåæ§ã«ããŠãèç¹208â210âïŒå解ïŒã®
ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâ
ïŒâïŒïŒâãã³ãžã«ãªãã·âããšãã«ïŒâãšã¿ãã³
ãªãã·ã å¡©é žå¡©2.2gãšèç¹210â212âã®ïŒïŒ¥ïŒâ
ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâãã³ãžã«ãªãã·âããšãã«ïŒâãšã¿ãã³ãªã
ã·ã å¡©é žå¡©0.7gããããåŸãã å®æœäŸ 34 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãšããã·âïŒâïŒïŒâããšãã«
ãšãã«ïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã å¡©é žå¡© ïŒâïŒïŒâããšãã«ãšãã«ïŒâã¢ã»ããã·ãã³ãŒ
ã³10.0gã«ããããã³ãŒã³40mlãç¡æ°Žå¡©äŸ¡ã¢ã«ã
ããŠã 7.2gãå ããçªçŽ é°å²æ°äž130âã§30åæª
æãããå·åŽåŸåå¿æ¶²ãæ°·ãšå¡©é žæ··åç©ã«ããã
ã¯ãããã«ã æœåºãæ°ŽæŽåŸãç¡æ°Žç¡«é žãããªãŠã
ã§ä¹Ÿç¥ãã也åºãããæ®æž£ã溶é¢æ¶²ãšããŠãã³ãŒ
ã³ïŒïœâãããµã³ïŒïŒïŒïŒïŒãçšããŠã·ãªã«ã²ã«
ã«ã©ã ã¯ãããã°ã©ãã€ãŒã§ç²Ÿè£œããïŒâïŒïŒâ
ããããã·âïŒâïŒïŒâããšãã«ãšãã«ïŒâããšã
ã«ïŒâãšã¿ãã³8.3gãæ²¹ç¶ç©ãšããŠåŸãã次ã«ã
ã®ããããã·äœ8.3gã䜿çšããŠå®æœäŸ33ãšåæ§ã«
ããŠïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒ
âïŒïŒâããããã·âïŒâïŒïŒâããšãã«ãšãã«ïŒ
âããšãã«ïŒâãšã¿ãã³5.4gãåŸãã次ã«ãã®ã
ãããã·äœ5.4ïœããã«ãšã³100mlã«æº¶è§£åŸãæ°Ž50
mlã«æº¶è§£ããæ°Žé žåã«ãªãŠã 3.2gãšããã©ããã«
ã¢ã³ã¢ããŠã ãããã0.6gãå ããçªçŽ é°å²æ°äž
宀枩ã§30åæªæããããã®åŸããžãšãã«ç¡«é ž3.7g
ãå ã90âã§ïŒæéæªæãããå·åŽåŸãå液ãã
ãã«ãšã³å±€ãæ°ŽæŽããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥
ãã30ïŒ å¡©é žâãšã¿ããŒã«3.2mlãå ãããæåº
çµæ¶ãåããïŒâãããããŒã«ããåçµæ¶ãè¡
ãªããèç¹163â166âã®ïŒâïŒïŒâã¡ãã«ããã©
ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâãšããã·âïŒâïŒïŒ
âããšãã«ãšãã«ïŒâããšãã«ïŒâãšã¿ãã³ïŒå¡©é ž
å¡©3.6gãåŸãã次ã«ãã®ãšã¿ãã³äœ3.6gãã¡ã¿ã
ãŒã«100mlã«æº¶è§£åŸãããªãšãã«ã¢ãã³ïŒmlãã
ãããã·ã«ã¢ãã³å¡©é žå¡©1.7gãå ãã以äžå®æœäŸ
ïŒãšåæ§ã«ããŠèç¹206â209âïŒå解ïŒã®ïŒïŒºïŒ
âïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâãšããã·âïŒâïŒïŒâããšãã«ãšãã«ïŒâã
ãšãã«ïŒâãšã¿ãã³ãªãã·ã å¡©é žå¡©1.5gãåŸãã å®æœäŸ 35 ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâïŒïŒâããšãã«ãšãã«ïŒâããšãã«ïŒâãšã¿
ãã³ãªãã·ã ç¡æ°Žé ¢é ž7.6gãããã©ãã€ãããã©ã³20mlã«æº¶
解ããçªçŽ é°å²æ°äžããã«ãã°ãã·ãŠã 1.0gãïŒ
âïŒïŒâããšãã«ãšãã«ïŒâããã¢ãã³ãŒã³10.0gã
ããã©ãã€ãããã©ã³30mlããåæããã°ãªãã€
ãŒã«ååç©ããâ60âæªæäž30åã§æ»ŽäžããæŽã«
ïŒæéæªæããããã®åŸåå¿æ¶²ãæ°·ãšé£œåå¡©åã¢
ã³ã¢ããŠã 氎溶液ã®æ··åç©ã«ããããªãšã³ã§æœåº
ãããå液åŸã2Nã»æ°Žé žåãããªãŠã 氎溶液ã
飜åé£å¡©æ°Žã§é 次æŽæ»ããç¡æ°Žç¡«é žãããªãŠã ã§
也ç¥åŸä¹Ÿåºãããæ®æž£ã溶é¢è§£ãšããŠãã³ãŒã³ïŒ
ïœâãããµã³ïŒïŒïŒïŒïŒãçšããŠã·ãªã«ã²ã«ã«ã©
ã ã¯ãããã°ã©ãã€ãŒã«ãã粟補ããïŒâïŒïŒâ
ïŒïŒâããšãã«ãšãã«ïŒâããšãã«ïŒâãšã¿ãã³7.9
ïœãæ²¹ç¶ç©ãšããŠåŸãã次ã«ãã®ã¢ã»ãããšãã³
äœ5.0gã䜿çšããå®æœäŸ33ãšåæ§ã«ããŠãèç¹
185â188âïŒå解ïŒã®ïŒïŒºïŒâïŒïŒâã¡ãã«ããã©
ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâïŒïŒâããšãã«ãšã
ã«ïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã å¡©é žå¡©3.8ïœ
ãšèç¹133â134âã®ïŒïŒ¥ïŒâïŒâïŒïŒâã¡ãã«ãã
ã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâïŒïŒâããšãã«ãš
ãã«ïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã 0.5gããã
ããåŸãã å®æœäŸ35ãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ã«ïŒâïŒâïŒïŒâãã³ãŒã³ã¹ã«ããã«ã¢ããâã
ãšãã«ïŒâãšã¿ãã³ãªãã·ã å®æœäŸïŒãšåæ§ã«ããŠåŸãããïŒâïŒïŒâã¡ã
ã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâã¢ã»ãã«ã¢
ããâããšãã«ïŒâãšã¿ãã³4.0ïœã«ãšã¿ããŒã«10
mlãšæ°Ž10mlã«æº¶è§£ããæ°Žé žåãããªãŠã 1.8ïœã
å ããçªçŽ é°å²æ°äž85âã§ïŒæéæªæããããã®
åŸããšã¿ããŒã«ãçå»ãæåºæ²¹ç¶ç©ãã¯ãããã«
ã ã§æœåºæ°ŽæŽããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸä¹Ÿ
åºããïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâ
ïŒâïŒïŒâã¢ããâããšãã«ïŒâãšã¿ãã³2.7gãåŸ
ãã 次ã«ãã®ã¢ããäœ2.7gã«ããªãžã³16mlãå ãã
æ°·å·æªæäžãã³ãŒã³ã¹ã«ããã«ã¯ããªã2.1gãå
ããããã®åŸå®€æž©ã§ïŒæéæªæããåŸããããã
ã·ã«ã¢ãã³å¡©é žå¡©1.6gãå ããã以äžå®æœäŸïŒãš
åæ§ã«ããŠèç¹196â199âïŒå解ïŒã®ïŒïŒºïŒâïŒ
âïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒ
âãã³ãŒã³ã¹ã«ããã«ã¢ããâããšãã«ïŒâãšã¿
ãã³ãªãã·ã 2.2ïœãåŸãã å®æœäŸ31ãšåæ§ã«ããŠãäžèšå®æœäŸ32ã®ååç©
ãåæããã å®æœäŸ 32 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâïŒïœâãã«ãšã³ã¹ã«ããã«ã¢ã
ãïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã èç¹192â193â å®æœäŸ 33 ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâãã³ãžã«ãªãã·âããšãã«ïŒâãšã¿ãã³ãª
ãã·ã å¡©é žå¡© ïŒâãã³ãžã«ãªãã·ã¢ã»ãããšãã³4.0gãïŒïŒ
ïŒâãžãªããµã³20mlãããã©ãã€ãããã©ã³20ml
ã«æº¶è§£åŸãæ°·å·æªæäžãç¡æ°Žå¡©åã¢ã«ãããŠã
0.1gãšèçŽ 3.1gãå ãããæŽã«æ°·å·äžïŒæéæªæ
ããåŸãåå¿æ¶²ã也åºããã æ®æž£ã«ãæ°Žãšã¯ãããã«ã ãå ãå液ããã¯ã
ããã«ã å±€ãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸä¹Ÿåº
ããã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ãŒã§ã溶
é¢æ¶²ãšããŠãã³ãŒã³ïŒïœâãããµã³ïŒïŒïŒïŒïŒã
çšããŠç²Ÿè£œããïŒâããã¢âïŒâïŒïŒâãã³ãžã«
ãªãã·âããšãã«ïŒâãšã¿ãã³ãªãã·ã 4.1gãåŸ
ãã次ã«ãã®ããã¢äœ3.0gã䜿çšãã以äžå®æœäŸ
ïŒãšåæ§ã«ããŠãèç¹208â210âïŒå解ïŒã®
ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâ
ïŒâïŒïŒâãã³ãžã«ãªãã·âããšãã«ïŒâãšã¿ãã³
ãªãã·ã å¡©é žå¡©2.2gãšèç¹210â212âã®ïŒïŒ¥ïŒâ
ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâãã³ãžã«ãªãã·âããšãã«ïŒâãšã¿ãã³ãªã
ã·ã å¡©é žå¡©0.7gããããåŸãã å®æœäŸ 34 ïŒïŒºïŒâïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€
ã«ïŒâïŒâïŒïŒâãšããã·âïŒâïŒïŒâããšãã«
ãšãã«ïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã å¡©é žå¡© ïŒâïŒïŒâããšãã«ãšãã«ïŒâã¢ã»ããã·ãã³ãŒ
ã³10.0gã«ããããã³ãŒã³40mlãç¡æ°Žå¡©äŸ¡ã¢ã«ã
ããŠã 7.2gãå ããçªçŽ é°å²æ°äž130âã§30åæª
æãããå·åŽåŸåå¿æ¶²ãæ°·ãšå¡©é žæ··åç©ã«ããã
ã¯ãããã«ã æœåºãæ°ŽæŽåŸãç¡æ°Žç¡«é žãããªãŠã
ã§ä¹Ÿç¥ãã也åºãããæ®æž£ã溶é¢æ¶²ãšããŠãã³ãŒ
ã³ïŒïœâãããµã³ïŒïŒïŒïŒïŒãçšããŠã·ãªã«ã²ã«
ã«ã©ã ã¯ãããã°ã©ãã€ãŒã§ç²Ÿè£œããïŒâïŒïŒâ
ããããã·âïŒâïŒïŒâããšãã«ãšãã«ïŒâããšã
ã«ïŒâãšã¿ãã³8.3gãæ²¹ç¶ç©ãšããŠåŸãã次ã«ã
ã®ããããã·äœ8.3gã䜿çšããŠå®æœäŸ33ãšåæ§ã«
ããŠïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒ
âïŒïŒâããããã·âïŒâïŒïŒâããšãã«ãšãã«ïŒ
âããšãã«ïŒâãšã¿ãã³5.4gãåŸãã次ã«ãã®ã
ãããã·äœ5.4ïœããã«ãšã³100mlã«æº¶è§£åŸãæ°Ž50
mlã«æº¶è§£ããæ°Žé žåã«ãªãŠã 3.2gãšããã©ããã«
ã¢ã³ã¢ããŠã ãããã0.6gãå ããçªçŽ é°å²æ°äž
宀枩ã§30åæªæããããã®åŸããžãšãã«ç¡«é ž3.7g
ãå ã90âã§ïŒæéæªæãããå·åŽåŸãå液ãã
ãã«ãšã³å±€ãæ°ŽæŽããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥
ãã30ïŒ å¡©é žâãšã¿ããŒã«3.2mlãå ãããæåº
çµæ¶ãåããïŒâãããããŒã«ããåçµæ¶ãè¡
ãªããèç¹163â166âã®ïŒâïŒïŒâã¡ãã«ããã©
ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâãšããã·âïŒâïŒïŒ
âããšãã«ãšãã«ïŒâããšãã«ïŒâãšã¿ãã³ïŒå¡©é ž
å¡©3.6gãåŸãã次ã«ãã®ãšã¿ãã³äœ3.6gãã¡ã¿ã
ãŒã«100mlã«æº¶è§£åŸãããªãšãã«ã¢ãã³ïŒmlãã
ãããã·ã«ã¢ãã³å¡©é žå¡©1.7gãå ãã以äžå®æœäŸ
ïŒãšåæ§ã«ããŠèç¹206â209âïŒå解ïŒã®ïŒïŒºïŒ
âïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâãšããã·âïŒâïŒïŒâããšãã«ãšãã«ïŒâã
ãšãã«ïŒâãšã¿ãã³ãªãã·ã å¡©é žå¡©1.5gãåŸãã å®æœäŸ 35 ïŒâïŒïŒâã¡ãã«ããã©ãžã³âïŒâã€ã«ïŒâïŒâ
ïŒïŒâïŒïŒâããšãã«ãšãã«ïŒâããšãã«ïŒâãšã¿
ãã³ãªãã·ã ç¡æ°Žé ¢é ž7.6gãããã©ãã€ãããã©ã³20mlã«æº¶
解ããçªçŽ é°å²æ°äžããã«ãã°ãã·ãŠã 1.0gãïŒ
âïŒïŒâããšãã«ãšãã«ïŒâããã¢ãã³ãŒã³10.0gã
ããã©ãã€ãããã©ã³30mlããåæããã°ãªãã€
ãŒã«ååç©ããâ60âæªæäž30åã§æ»ŽäžããæŽã«
ïŒæéæªæããããã®åŸåå¿æ¶²ãæ°·ãšé£œåå¡©åã¢
ã³ã¢ããŠã 氎溶液ã®æ··åç©ã«ããããªãšã³ã§æœåº
ãããå液åŸã2Nã»æ°Žé žåãããªãŠã 氎溶液ã
飜åé£å¡©æ°Žã§é 次æŽæ»ããç¡æ°Žç¡«é žãããªãŠã ã§
也ç¥åŸä¹Ÿåºãããæ®æž£ã溶é¢è§£ãšããŠãã³ãŒã³ïŒ
ïœâãããµã³ïŒïŒïŒïŒïŒãçšããŠã·ãªã«ã²ã«ã«ã©
ã ã¯ãããã°ã©ãã€ãŒã«ãã粟補ããïŒâïŒïŒâ
ïŒïŒâããšãã«ãšãã«ïŒâããšãã«ïŒâãšã¿ãã³7.9
ïœãæ²¹ç¶ç©ãšããŠåŸãã次ã«ãã®ã¢ã»ãããšãã³
äœ5.0gã䜿çšããå®æœäŸ33ãšåæ§ã«ããŠãèç¹
185â188âïŒå解ïŒã®ïŒïŒºïŒâïŒïŒâã¡ãã«ããã©
ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâïŒïŒâããšãã«ãšã
ã«ïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã å¡©é žå¡©3.8ïœ
ãšèç¹133â134âã®ïŒïŒ¥ïŒâïŒâïŒïŒâã¡ãã«ãã
ã©ãžã³âïŒâã€ã«ïŒâïŒâïŒïŒâïŒïŒâããšãã«ãš
ãã«ïŒâããšãã«ïŒâãšã¿ãã³ãªãã·ã 0.5gããã
ããåŸãã å®æœäŸ35ãšåæ§ã«ããŠä»¥äžã®ååç©ãåæã
ãã
ãè¡šã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžèšäžè¬åŒïŒïŒ ãäžèšåŒäžãR1ã¯ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åºã
ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºåã³ããã²ã³ååã
ãéžã°ãã眮æåºã§çœ®æãããŠããŠãããã·ã¯ã
ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ã©ã«ãã«åºãã¢ãªãŒ
ã«ãªãã·åºãã¢ã©ã«ãã«ãªãã·åºãã¢ãªãŒã«ããª
åºè¥ããã¯ã¢ãªãŒã«ã¹ã«ããã«åºããããªãžã
åºãããã©ãžãåºãïŒâã¢ã«ãã«çœ®æããã©ãžã
åºãã€ãããŸãªã«åºãïŒâã¢ã«ãã«çœ®æã€ãããŸ
ãªã«åºãŸãã¯ããšãã«åºãã¢ã»ãã«åºããã³ãŒã³
ã¹ã«ããã«åºããã³ïœâãã«ãšã³ã¹ã«ãã€ã«åºã
ãéžã°ããïŒä»¥äžã®çœ®æåºã§çœ®æãããã¢ããåº
ãè¡šããã R2ã¯æ°ŽçŽ ååãŸãã¯ççŽ æ°ïŒãïŒã®ã¢ã«ã³ã
ã·åºãè¡šããã R3ã¯ãããªãžãåºãããã©ãžãåºãŸãã¯ïŒâ
ã¢ã«ãã«çœ®æããã©ãžãåºãè¡šããã ãŸããR1åã³R2ã¯äºãã«çµåããŠããšãã«åº
ãšå ±ã«ããšããã¢ãžã³âïŒâã€ã«åºãâã¢ã»ã
ã«âããšããã¢ãžã³âïŒâã€ã«åºããã¢ã³ãã¬ã³
âïŒâã€ã«åºããžãã³ãŸããªããšã³âïŒâã€ã«
åºããžãã³ãŸãã©ã³âïŒâã€ã«åºè¥ããã¯æ¬¡åŒ
ãåŒã ïŒåŒäžãR4ã¯æ°ŽçŽ ååãŸãã¯ççŽ æ°ïŒãïŒã®
ã¢ã«ãã«åºãè¡šãããïŒã§ç€ºãããåºãè¡šãããŠ
ããããã ã§è¡šãããããšã¿ãã³ãªãã·ã é¡ãŸãã¯è¬å€ãšã
ãŠèš±å®¹ããããã®é žä»å å¡©ã
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62220877A JPS6463574A (en) | 1987-09-03 | 1987-09-03 | Ethanone oximes |
US07/239,169 US4933344A (en) | 1987-09-03 | 1988-08-31 | Ethanone oximes and pharmaceutical compositions thereof |
AT88402203T ATE83233T1 (de) | 1987-09-03 | 1988-09-01 | Ethanon-oxime. |
EP88402203A EP0306411B1 (en) | 1987-09-03 | 1988-09-01 | Ethanone oximes |
DE8888402203T DE3876546T2 (de) | 1987-09-03 | 1988-09-01 | Ethanon-oxime. |
HU884512A HU201036B (en) | 1987-09-03 | 1988-09-01 | Process for production of derivatives of ethanon-oxim and medical compositions containing them as active substance |
CA000576488A CA1338711C (en) | 1987-09-03 | 1988-09-02 | Ethanone oximes |
KR1019880011433A KR960001206B1 (ko) | 1987-09-03 | 1988-09-03 | ìíìš ì¥ì¬ |
US07/501,591 US4977151A (en) | 1987-09-03 | 1990-03-29 | Ethanone oximes and pharmaceutical compositions thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62220877A JPS6463574A (en) | 1987-09-03 | 1987-09-03 | Ethanone oximes |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6463574A JPS6463574A (en) | 1989-03-09 |
JPH0465067B2 true JPH0465067B2 (ja) | 1992-10-16 |
Family
ID=16757937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62220877A Granted JPS6463574A (en) | 1987-09-03 | 1987-09-03 | Ethanone oximes |
Country Status (8)
Country | Link |
---|---|
US (2) | US4933344A (ja) |
EP (1) | EP0306411B1 (ja) |
JP (1) | JPS6463574A (ja) |
KR (1) | KR960001206B1 (ja) |
AT (1) | ATE83233T1 (ja) |
CA (1) | CA1338711C (ja) |
DE (1) | DE3876546T2 (ja) |
HU (1) | HU201036B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994018172A1 (en) * | 1993-02-01 | 1994-08-18 | Yoshitomi Pharmaceutical Industries, Ltd. | Imidazolylbenzene compound and use thereof as medicine |
US5665756A (en) * | 1994-08-03 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
JP2007197390A (ja) * | 2006-01-27 | 2007-08-09 | Fujifilm Corp | ãªãã·ã èªå°äœãæå æ§çµæç©ããã¿ãŒã³åœ¢æææãæå æ§ç©å±€äœã䞊ã³ã«ãã¿ãŒã³åœ¢æè£ çœ®åã³ãã¿ãŒã³åœ¢ææ¹æ³ |
KR102423976B1 (ko) * | 2014-08-01 | 2022-07-22 | ê°ë¶ìí€ê°ìŽì€ ìë°ì¹Ž | ì ê· ì€í© ê°ìì ë° ìêž° ì€í© ê°ìì 륌 íšì íë ëŒë칌 ì€í©ì± ì¡°ì±ë¬Œ |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3639612A (en) * | 1969-05-16 | 1972-02-01 | Lilly Co Eli | Chalcogen containing heterocyclics as an in vitro anti-viral agent |
JPS5321023B2 (ja) * | 1971-10-06 | 1978-06-30 | ||
FR2162312B1 (ja) * | 1971-12-10 | 1975-02-07 | Buzas Andre | |
US4352804A (en) * | 1978-07-25 | 1982-10-05 | Acf Chemiefarma Nv | Oxime ethers, their preparation and pharmaceutical compositions containing them |
DE3508398A1 (de) * | 1985-03-08 | 1986-11-06 | Hoechst Ag, 6230 Frankfurt | Fungizide mittel auf der basis von 3-(hetero)-arylpropylaminen sowie neue (hetero)-aryl-propylamine und verfahren zu ihrer herstellung |
-
1987
- 1987-09-03 JP JP62220877A patent/JPS6463574A/ja active Granted
-
1988
- 1988-08-31 US US07/239,169 patent/US4933344A/en not_active Expired - Fee Related
- 1988-09-01 EP EP88402203A patent/EP0306411B1/en not_active Expired - Lifetime
- 1988-09-01 AT AT88402203T patent/ATE83233T1/de not_active IP Right Cessation
- 1988-09-01 DE DE8888402203T patent/DE3876546T2/de not_active Expired - Fee Related
- 1988-09-01 HU HU884512A patent/HU201036B/hu not_active IP Right Cessation
- 1988-09-02 CA CA000576488A patent/CA1338711C/en not_active Expired - Fee Related
- 1988-09-03 KR KR1019880011433A patent/KR960001206B1/ko not_active IP Right Cessation
-
1990
- 1990-03-29 US US07/501,591 patent/US4977151A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE83233T1 (de) | 1992-12-15 |
EP0306411A2 (en) | 1989-03-08 |
US4977151A (en) | 1990-12-11 |
DE3876546T2 (de) | 1993-04-15 |
EP0306411B1 (en) | 1992-12-09 |
CA1338711C (en) | 1996-11-12 |
KR890005068A (ko) | 1989-05-11 |
JPS6463574A (en) | 1989-03-09 |
EP0306411A3 (en) | 1990-05-30 |
HU201036B (en) | 1990-09-28 |
HUT47535A (en) | 1989-03-28 |
DE3876546D1 (de) | 1993-01-21 |
KR960001206B1 (ko) | 1996-01-24 |
US4933344A (en) | 1990-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880001008B1 (ko) | ìí¬ì€í°ì믞ëíëìí¬ì믌 ë° ìŽì ì ì¡°ë°©ë² | |
US4689341A (en) | Antiarrhythmic imidazoles | |
JP2637737B2 (ja) | æ°èŠãªè¬å€ | |
EP0883613A1 (en) | Sulfonamide derivatives as 5ht7 receptor antagonists | |
CS216544B2 (en) | Method of preparation of basic ethers | |
US5296498A (en) | Guanidine compounds | |
EP0015156A1 (en) | Basically-substituted tricyclic pyrazoles, their preparation and their use as antiinflammatory agents | |
KR900006118B1 (ko) | 4-íŽëë¡ ì ë첎ì ì ë² | |
JPH0465067B2 (ja) | ||
US4616017A (en) | Aminohydroxypropoxy substituted aryl compounds | |
US4539318A (en) | Tertiary aminohydroxypropoxy substituted thiadiazoles, pharmaceutical compositions and use | |
US3970757A (en) | Tetrahydro-carbazole derivatives as gastric anti-secretory agents | |
HU203345B (en) | Process for producing ergoline derivatives and pharmaceutical compositions comprising same | |
US4980362A (en) | 4-substituted-2-alkoxytetrahydrofuran derivatives | |
US4613609A (en) | Antiarrhythmic imidazoliums | |
HU208970B (en) | Process for producing new thienloxyalkyl derivatives and pharmaceutical compositions comprising same | |
JPS6410512B2 (ja) | ||
EP0034752B1 (en) | Phenoxyalkane derivative and processes for preparing same | |
HU180492B (en) | Process for preparing indolizine derivatives and pharmaceutical composition containing such compounds as active materials | |
KR960005463B1 (ko) | 2-í°ìëì¥ìììžížì° ì ë첎, ìŽì ì ì¡°ë°©ë² ë° ìŽë¥Œ íšì íë ìœì | |
EP0318234A2 (en) | Improvements in or relating to selective serotonin uptake inhibitors | |
JPH02225413A (ja) | æ朰çå€ | |
JPS625982A (ja) | ãã¢ãŸãªãžã³èªå°äœ | |
HU196363B (en) | Process for production of new aryl-sulphon compositions and medical preparatives containing them as filling material | |
RU2045521C1 (ru) | ÐÑПОзвПЎМÑе 1,2,4-ÑÑОазПлОлÑОПаЌОЎПв |